Gordon Syndrome

Mendelian MONDO:0007252 Pathograph 21 Show in embeddings browser distal arthrogryposis multiple congenital anomalies/dysmorphic syndrome without intellectual disability

Gordon syndrome (distal arthrogryposis type 3, DA3) is a rare autosomal dominant multiple congenital malformation syndrome defined by congenital contractures of the hands and feet, chiefly camptodactyly and clubfoot, with cleft palate in a minority of affected people. Short stature, scoliosis, ptosis, micrognathia, pectus excavatum and cryptorchidism occur in some individuals, and intelligence is usually normal. Penetrance is reduced and expressivity variable, with more reduced penetrance in females. Gordon syndrome is caused by heterozygous variants in PIEZO2, which encodes the principal mechanically activated cation channel of proprioceptive and touch sensory neurons; most families carry the recurrent c.8057G>A (p.Arg2686His) variant, which is significantly associated with cleft palate. The dominant PIEZO2 variants studied electrophysiologically make the channel recover faster from inactivation, increasing channel activity for a given mechanical stimulus, and a mouse carrying such a gain-of-function allele in proprioceptive sensory neurons develops shortened tendons and joint contractures. Gordon syndrome is allelic with distal arthrogryposis type 5 and Marden-Walker syndrome, which McMillin et al. regard as possibly variable expressions of one PIEZO2-related condition.

Ask OpenScientist

Ask a research question about Gordon Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
5
Pathophys.
18
Phenotypes
1
Gaps
21
Pathograph
1
Genes
2
Variants
2
Medical Actions
4
Differentials
1
Models
3
References
1
Deep Research
🏷

Classifications

Harrison's Part
GENETICS ENVIRONMENT DISEASE
👪

Inheritance

1
Autosomal dominant inheritance with reduced penetrance HP:0000006
Gordon syndrome segregates as an autosomal dominant trait in multigeneration families, with reduced penetrance and variable expressivity. Penetrance is lower in females than in males, and in one five-generation family every asymptomatic carrier was female. A probably de novo PIEZO2 variant has been reported in a fetus of unaffected parents, in whom parental germline mosaicism could not be excluded.
Autosomal dominant inheritance Penetrance: INCOMPLETE Expressivity: VARIABLE
Show evidence (4 references)
PMID:24726473 SUPPORT Human Clinical
"Gordon syndrome (GS), or distal arthrogryposis type 3, is a rare, autosomal-dominant disorder characterized by cleft palate and congenital contractures of the hands and feet."
The gene-discovery study describes Gordon syndrome as an autosomal dominant disorder.
PMID:458832 SUPPORT Human Clinical
"A second family is described in which camptodactyly, club foot, and cleft palate (the Gordon syndrome) is transmitted in a pattern consistent with autosomal dominant inheritance with reduced penetrance and variable expressivity."
A large pedigree shows autosomal dominant transmission with reduced penetrance and variable expressivity.
PMID:8370149 SUPPORT Human Clinical
"Penetrance is more reduced in females than in males and asymptomatic carriers are always females."
A five-generation family shows the sex difference in penetrance: all asymptomatic carriers were female.
+ 1 more reference
?

Discussions and Knowledge Gaps

1
Does the Gordon syndrome variant p.Arg2686His act through the same proprioceptive-neuron efferent mechanism shown for a distal arthrogryposis type 5 allele in mice, and is there a corresponding developmental window in humans during which reducing PIEZO2 activity would prevent contractures?
HUMAN MODEL MISMATCH OPEN gordon_sensory_neuron_mechanism_translation
The sensory-neuron mechanism and the botulinum toxin and EPA rescues come from a mouse carrying the DA5 allele E2727del, with a postnatal critical window. Gordon syndrome is mostly caused by p.Arg2686His, which has not been electrophysiologically characterized or modelled in the cited sources, and its contractures are present before birth. Whether the mechanism and the window transfer decides whether the mouse rescues have any bearing on Gordon syndrome.
Show evidence (1 reference)
PMID:36634173 SUPPORT Model Organism
"We also present proof-of-concept that Botox injection or dietary treatment can counteract the effect of overactive PIEZO2 function to evade DA-like phenotypes in mice when applied during a developmental critical period."
The rescue is shown in mice and only within a developmental window.
⚙

Pathophysiology

5
PIEZO2 Gain-of-Function and Mechanotransduction Defect
Mechanism confidence: Established
Heterozygous dominant PIEZO2 variants alter the kinetics of the mechanically activated channel rather than abolishing it. The dominant variants characterized by patch clamp (E2727del and I802F, from distal arthrogryposis type 5 families) make PIEZO2-dependent currents recover faster from inactivation, and E2727del also slows inactivation, so the channel passes more current for a given mechanical stimulus. Mutant channels are not constitutively open and are not toxic to cells. The recurrent Gordon syndrome variant p.Arg2686His is treated as acting the same way by inference from these alleles. The node name is shared with the Marden-Walker syndrome entry because the lesion is the same.
PIEZO2 hgnc:26270 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves PIEZO2 (hgnc:26270). hgnc:26270 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context variant_origin: GERMLINE zygosity: HETEROZYGOUS functional_impact_category: GAIN_OF_FUNCTION
Heterozygous germline variants, most often c.8057G>A (p.Arg2686His).
detection of mechanical stimulus GO:0050982 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased detection of mechanical stimulus (GO:0050982). GO:0050982 is a biological process from the Gene Ontology.
mechanosensitive cation channel activity GO:0008381 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves increased mechanosensitive cation channel activity, annotated with mechanosensitive monoatomic ion channel activity (GO:0008381). GO:0008381 is a molecular function from the Gene Ontology.
Show evidence (3 references)
PMID:23487782 SUPPORT INDIRECT In Vitro
"both E2727del and I802F mutations cause the PIEZO2-dependent, mechanically activated currents to recover faster from inactivation, while E2727del also causes a slowing of inactivation."
Patch-clamp characterization of two dominant PIEZO2 variants. Indirect for Gordon syndrome because the alleles come from distal arthrogryposis type 5 families.
PMID:23487782 SUPPORT INDIRECT In Vitro
"We further show that overexpression of mutated PIEZO2 cDNAs does not cause constitutive activity or toxicity to cells, indicating that the observed phenotype is likely due to a mechanotransduction defect."
Shows the defect is altered mechanotransduction rather than constitutive opening or cytotoxicity.
PMID:27843126 SUPPORT BACKGROUND Human Clinical
"In contrast, heterozygous gain-of-function missense mutations, mainly localized at the C terminus, cause dominant distal arthrogryposis 3 (DA3), distal arthrogryposis 5 (DA5), or Marden-Walker syndrome (MWKS), which encompass contractures of hands and feet, scoliosis, ophthalmoplegia, and ptosis."
States that DA3 (Gordon syndrome) is caused by heterozygous gain-of-function C-terminal PIEZO2 missense variants.
Incomplete Secondary Palate Fusion
Mechanism confidence: Provisional
Failure of the secondary palate to close completely, giving cleft palate or its minor form, bifid uvula. In Gordon syndrome this is the least often expressed element of the classic triad and is significantly associated with the recurrent p.Arg2686His variant. How altered PIEZO2 mechanotransduction affects palatal shelf development is not known; the node is PROVISIONAL because the link to PIEZO2 is a genotype-phenotype association rather than a demonstrated mechanism.
secondary palate development GO:0062009 ⚠ ABNORMAL Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal secondary palate development (GO:0062009). GO:0062009 is a biological process from the Gene Ontology.
secondary palate UBERON:0001716 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in secondary palate (UBERON:0001716). UBERON:0001716 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:24726473 SUPPORT Human Clinical
"The presence of cleft palate was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001)."
Allele-specific association with cleft palate.
PMID:27714920 SUPPORT Human Clinical
"Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
Bifid uvula or cleft palate in a PIEZO2-positive family.
Excessive Mechanotransduction in Proprioceptive Sensory Neurons
Mechanism confidence: Provisional
PIEZO2 is the principal mechanotransduction channel of proprioceptive sensory neurons, which innervate muscle spindles and tendon organs. In mice, expressing a gain-of-function Piezo2 allele only in these neurons is sufficient to reproduce the limb contractures, whereas expressing it only in limb mesenchyme (muscle, cartilage and tendon) is not. The effect depends on neuronal activity during a postnatal developmental window, and botulinum toxin, but not motor-endplate blockade with alpha-bungarotoxin, prevents it. The authors interpret this as an efferent action of the afferent nerve endings, likely through increased exocytosis, rather than increased reflex motor drive; stretch-evoked muscle spindle afferent firing was not increased ex vivo. The node is PROVISIONAL because the evidence is from a mouse carrying a distal arthrogryposis type 5 allele, not the Gordon syndrome variant.
proprioceptive sensory neuron CL:1001451 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves proprioceptive sensory neuron, annotated with sensory neuron of dorsal root ganglion (CL:1001451). CL:1001451 is a cell type from the Cell Ontology.
detection of mechanical stimulus GO:0050982 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased detection of mechanical stimulus (GO:0050982). GO:0050982 is a biological process from the Gene Ontology.
muscle spindle UBERON:0003718 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in muscle spindle (UBERON:0003718). UBERON:0003718 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (6 references)
PMID:27843126 SUPPORT BACKGROUND Human Clinical
"PIEZO2 encodes a mechanosensitive ion channel that plays a major role in light-touch mechanosensation and has recently been identified as the principal mechanotransduction channel for proprioception."
Identifies the proprioceptive neuron as the main cellular site of PIEZO2 function.
PMID:27184818 SUPPORT Model Organism
"The data clearly shows that Piezo2 fulfills a critical role in a defined homogeneous population of proprioceptor neurons that innervate the head muscles, demonstrating that this ion channel is essential for mammalian proprioceptive mechanotransduction."
Conditional deletion in mice shows PIEZO2 carries the mechanically activated current of proprioceptive neurons, the cell type whose overactivity this node describes.
PMID:36634173 SUPPORT INDIRECT Model Organism
"We show that expression of a gain-of-function PIEZO2 mutation in proprioceptive sensory neurons that mainly innervate muscle spindles and tendons is sufficient to induce DA5-like phenotypes in mice."
Cell-type-restricted expression locates the pathogenic action in proprioceptive sensory neurons.
+ 3 more references
Tendon Shortening and Disrupted Musculoskeletal Development
Mechanism confidence: Provisional
In gain-of-function Piezo2 mice the hindlimb tendons are shorter than in wild-type littermates, and the authors propose that shortened tendons produce the contractures. Proprioceptive nerve endings and muscle fiber diameters looked normal, so the defect is in tendon and joint development rather than in sensory-ending formation or muscle growth. Mouse-derived; tendon length has not been measured in people with Gordon syndrome in the cited sources.
tendon development GO:0035989 ⚠ ABNORMAL Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal tendon development (GO:0035989). GO:0035989 is a biological process from the Gene Ontology.
tendon UBERON:0000043 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in tendon (UBERON:0000043). UBERON:0000043 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:36634173 SUPPORT INDIRECT Model Organism
"we observed that the average length of tendons was significantly reduced in GOFconst. mice compared to wild type"
Measured tendon shortening in the gain-of-function mouse.
Congenital Distal Joint Contractures
Mechanism confidence: Established
The defining lesion: fixed contractures present from birth, chiefly at the finger joints (camptodactyly) and feet (clubfoot), sometimes extending to elbows, shoulders, knees and ankles. Contractures can be detected on prenatal ultrasound from the first trimester. The spinal curve seen in some patients has the characteristics of an arthrogrypotic neuromuscular curve.
hand UBERON:0002398 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in hand, annotated with manus (UBERON:0002398). UBERON:0002398 is an anatomical location from the Uberon multi-species anatomy ontology. foot UBERON:0002387 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in foot, annotated with pes (UBERON:0002387). UBERON:0002387 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (3 references)
PMID:24726473 SUPPORT Human Clinical
"Gordon syndrome (GS), or distal arthrogryposis type 3, is a rare, autosomal-dominant disorder characterized by cleft palate and congenital contractures of the hands and feet."
Congenital hand and foot contractures define the disorder.
PMID:27714920 SUPPORT Human Clinical
"Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
Documents distal and large-joint contractures in a PIEZO2-positive family.
PMID:36634173 SUPPORT INDIRECT Model Organism
"We observed that hindlimbs of the transgenic mice had contractures compared to wild type littermates"
The gain-of-function mouse reproduces distal limb contractures.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Gordon Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

18
Ear 1
Hearing impairment OCCASIONAL HP:0000365 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hearing impairment (HP:0000365). HP:0000365 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:376 SUPPORT Other
"HP:0000365 | Hearing impairment | Occasional (29-5%)"
Orphanet grades hearing impairment as occasional.
Eye 1
Ptosis HP:0000508 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ptosis (HP:0000508). HP:0000508 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27714920 SUPPORT Human Clinical
"Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
Ptosis in a PIEZO2-positive family.
ORPHA:376 SUPPORT Other
"Intelligence is normal but in some cases, additional abnormalities, such as short stature, kyphoscoliosis, ptosis, micrognathia, and cryptorchidism may also be present."
Orphanet lists ptosis among the variable additional features.
Genitourinary 1
Cryptorchidism OCCASIONAL HP:0000028 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cryptorchidism (HP:0000028). HP:0000028 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:376 SUPPORT Other
"HP:0000028 | Cryptorchidism | Occasional (29-5%)"
Orphanet grades cryptorchidism as occasional.
PMID:8370149 SUPPORT Human Clinical
"A family is reported in which camptodactyly, club foot, pectus excavatum and undescended testes are transmitted as an autosomal dominant with reduced penetrance and variable expressivity, affecting 13 members through five generations."
Undescended testes segregating in a five-generation family.
Head and Neck 6
Cleft palate OCCASIONAL HP:0000175 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cleft palate (HP:0000175). HP:0000175 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
ORPHA:376 SUPPORT Other
"HP:0000175 | Cleft palate | Occasional (29-5%)"
Orphanet grades cleft palate as occasional.
PMID:11718203 SUPPORT BACKGROUND Human Clinical
"Gordon's Syndrome is described as an autosomal dominant condition with the characteristics of short stature, a stiff spine, camptodactyly (89%), cleft palate (27%) and club feet (73%)."
Literature-derived frequency of cleft palate (27%).
PMID:458832 SUPPORT Human Clinical
"Penetrance appears to be more reduced in females than in males, and cleft palate is the least frequently manifested trait."
Cleft palate is the least often expressed component in a large pedigree.
High palate FREQUENT HP:0000218 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is High palate (HP:0000218). HP:0000218 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:376 SUPPORT Other
"HP:0000218 | High palate | Frequent (79-30%)"
Orphanet grades high palate as frequent.
Bifid uvula HP:0000193 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bifid uvula (HP:0000193). HP:0000193 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27714920 SUPPORT Human Clinical
"Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
Reports bifid uvula or cleft palate in the family.
Micrognathia HP:0000347 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Micrognathia (HP:0000347). HP:0000347 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:37587573 SUPPORT Human Clinical
"We describe a fetus from a Chinese family whose parents were both healthy but showed multiple malformations, including clubfoot, camptodactyly, micrognathia, and cleft palate."
Micrognathia in a PIEZO2-positive fetus.
ORPHA:376 SUPPORT Other
"Intelligence is normal but in some cases, additional abnormalities, such as short stature, kyphoscoliosis, ptosis, micrognathia, and cryptorchidism may also be present."
Orphanet lists micrognathia among the variable additional features.
Limited mouth opening Trismus HP:0000211 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Limited mouth opening, annotated with Trismus (HP:0000211). HP:0000211 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:34038001 SUPPORT Human Clinical
"He had a significant limitation of mouth opening (2 cm at incisors)."
Documents restricted mouth opening in a patient with Gordon syndrome.
Dandy-Walker malformation HP:0001305 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dandy-Walker malformation (HP:0001305). HP:0001305 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36588752 SUPPORT Human Clinical
"The brain MRI of the 2 patients showed Dandy-Walker malformation (DWM)."
One of the two patients with Dandy-Walker malformation had typical Gordon syndrome with p.Arg2686His.
Limbs 2
Camptodactyly of fingers VERY_FREQUENT HP:0100490 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Camptodactyly of finger (HP:0100490). HP:0100490 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:376 SUPPORT Other
"HP:0100490 | Camptodactyly of finger | Very frequent (99-80%)"
Orphanet grades camptodactyly as very frequent.
PMID:11718203 SUPPORT BACKGROUND Human Clinical
"Gordon's Syndrome is described as an autosomal dominant condition with the characteristics of short stature, a stiff spine, camptodactyly (89%), cleft palate (27%) and club feet (73%)."
Literature-derived frequency of camptodactyly (89%).
Clubfoot FREQUENT Talipes equinovarus HP:0001762 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Clubfoot, annotated with Talipes equinovarus (HP:0001762). HP:0001762 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:11718203 SUPPORT BACKGROUND Human Clinical
"Gordon's Syndrome is described as an autosomal dominant condition with the characteristics of short stature, a stiff spine, camptodactyly (89%), cleft palate (27%) and club feet (73%)."
Literature-derived frequency of club feet (73%).
PMID:37587573 SUPPORT Human Clinical
"We describe a fetus from a Chinese family whose parents were both healthy but showed multiple malformations, including clubfoot, camptodactyly, micrognathia, and cleft palate."
Clubfoot in a PIEZO2-positive fetus.
Musculoskeletal 5
Distal arthrogryposis HP:0005684 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Distal arthrogryposis (HP:0005684). HP:0005684 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24726473 SUPPORT Human Clinical
"Gordon syndrome (GS), or distal arthrogryposis type 3, is a rare, autosomal-dominant disorder characterized by cleft palate and congenital contractures of the hands and feet."
Defines the disorder by congenital hand and foot contractures.
ORPHA:376 SUPPORT Other
"Gordon syndrome, also known as distal arthrogryposis type 3, is an extremely rare multiple congenital malformation syndrome characterized by congenital contractures of hand and feet with variable degrees of severity of camptodactyly, clubfoot and, less frequently, cleft palate."
Orphanet definition of the disorder.
Large-joint contractures OCCASIONAL Limitation of joint mobility HP:0001376 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Limitation of joint mobility (HP:0001376). HP:0001376 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:376 SUPPORT Other
"HP:0001376 | Limitation of joint mobility | Occasional (29-5%)"
Orphanet grades limitation of joint mobility as occasional.
PMID:27714920 SUPPORT Human Clinical
"Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
Elbow, shoulder, knee and ankle contractures in a PIEZO2-positive family.
Scoliosis OCCASIONAL HP:0002650 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Scoliosis (HP:0002650). HP:0002650 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:376 SUPPORT Other
"HP:0002650 | Scoliosis | Occasional (29-5%)"
Orphanet grades scoliosis as occasional.
PMID:11718203 SUPPORT Human Clinical
"The authors present a case report of a patient with this rare entity complicated by an unusual complex spinal deformity."
Case report of complex spinal deformity in Gordon syndrome.
Pectus excavatum OCCASIONAL HP:0000767 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pectus excavatum (HP:0000767). HP:0000767 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:376 SUPPORT Other
"HP:0000767 | Pectus excavatum | Occasional (29-5%)"
Orphanet grades pectus excavatum as occasional.
PMID:8370149 SUPPORT Human Clinical
"A family is reported in which camptodactyly, club foot, pectus excavatum and undescended testes are transmitted as an autosomal dominant with reduced penetrance and variable expressivity, affecting 13 members through five generations."
Pectus excavatum segregating in a five-generation family.
Decreased muscle mass FREQUENT HP:0003199 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Decreased muscle mass (HP:0003199). HP:0003199 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:376 SUPPORT Other
"HP:0003199 | Decreased muscle mass | Frequent (79-30%)"
Orphanet grades decreased muscle mass as frequent.
Nervous System 1
Mild intellectual disability HP:0001256 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Mild intellectual disability (HP:0001256). HP:0001256 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27714920 SUPPORT Human Clinical
"Our analysis indicated that mild delay in psychomotor development and intellectual disability could be part of the phenotypic spectrum of Gordon syndrome."
Mild intellectual disability in one PIEZO2-positive family.
ORPHA:376 REFUTE Other
"Intelligence is normal but in some cases, additional abnormalities, such as short stature, kyphoscoliosis, ptosis, micrognathia, and cryptorchidism may also be present."
Orphanet describes intelligence as normal in Gordon syndrome.
Growth 1
Short stature OCCASIONAL HP:0004322 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short stature (HP:0004322). HP:0004322 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:376 SUPPORT Other
"HP:0004322 | Short stature | Occasional (29-5%)"
Orphanet grades short stature as occasional.
PMID:27714920 SUPPORT Human Clinical
"It is distinguishable from other forms of distal arthrogryposis by cleft palate and short stature."
Short stature as a distinguishing feature.
🧬

Genetic Associations

1
PIEZO2 (Causative (heterozygous, dominant))
Gene: PIEZO2 hgnc:26270 gene page HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is PIEZO2 (hgnc:26270). hgnc:26270 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (4 references)
PMID:24726473 SUPPORT Human Clinical
"Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family."
Identifies PIEZO2 as the Gordon syndrome gene.
PMID:27714920 SUPPORT Human Clinical
"In all affected family members, we identified the PIEZO2 mutation c.8057G>A (p.Arg2686His) by Sanger sequencing."
Independent replication in a three-generation family with the recurrent variant segregating with disease.
PMID:28728825 SUPPORT REVIEW SYNTHESIS Other
"Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis."
A review places the dominant distal arthrogryposes, of which Gordon syndrome is one, under PIEZO2 gain of function.
+ 1 more reference
Variants (2)
PIEZO2 c.8057G>A (p.Arg2686His) Pathogenic
The recurrent Gordon syndrome variant, shared by nine families in the gene-discovery series and reported independently in a three-generation family and in a girl with Gordon syndrome and Dandy-Walker malformation. Cleft palate is significantly associated with this variant. The cited sources do not report a patch-clamp characterization of this specific variant; its gain-of-function action is inferred from the electrophysiology of other dominant PIEZO2 variants.
Show evidence (3 references)
PMID:24726473 SUPPORT Human Clinical
"Sanger sequencing revealed PIEZO2 mutations in five of seven additional families studied (for a total of 10/12 [83%] individuals), and nine families had an identical c.8057G>A (p.Arg2686His) mutation."
Establishes p.Arg2686His as the recurrent Gordon syndrome variant.
PMID:24726473 SUPPORT Human Clinical
"The presence of cleft palate was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001)."
Genotype-phenotype association between this variant and cleft palate.
PMID:36588752 SUPPORT Human Clinical
"In addition, another girl with the typical clinical features of GS is also described carrying the most prevalent reported variant (c.8057G>A, p.R2686H) in PIEZO2."
Further report of the recurrent variant in typical Gordon syndrome.
PIEZO2 c.8576G>A (p.Trp2859*) Uncertain Significance
A heterozygous nonsense variant in exon 56, classified by the reporting authors as of uncertain significance, found in a fetus with clubfoot, camptodactyly, micrognathia and cleft palate and absent from both parents. Its effect on the channel has not been tested.
Show evidence (1 reference)
PMID:37587573 SUPPORT Human Clinical
"Whole-exome sequencing revealed that the fetus was heterozygous for a novel variant of uncertain significance in exon 56 (c.8576G>A; p.Trp2859*) of the Piezo-type mechanosensitive ion channel component 2 gene (PIEZO2) (NM_001378183.1)."
Reports the variant, its location and its uncertain-significance classification.
💊

Medical Actions

2
Orthopedic surgery for contractures and spinal deformity
Action: orthopedic surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is orthopedic surgical procedure (NCIT:C16186). NCIT:C16186 is a clinical intervention from the NCI Thesaurus. Ontology label: Orthopedic Surgical Procedure NCIT:C16186
Platform: Surgery
Surgical correction of clubfoot and contractures, and of scoliosis when present. The spinal curve behaves like an arthrogrypotic neuromuscular curve and needs extensive soft tissue release for correction. No disease-specific therapy exists.
Target Phenotypes: Scoliosis HP:0002650 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Scoliosis (HP:0002650). HP:0002650 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:11718203 SUPPORT Human Clinical
"Scoliosis in Gordon's Syndrome shares the characteristics of an arthrogrypotic neuromuscular curve and demands extensive soft tissue release for optimal correction."
Surgical guidance from a case of scoliosis in Gordon syndrome.
PMID:33104047 SUPPORT INDIRECT Human Clinical
"In terms of walking ability, 98% of participants with DA were independent ambulators."
Functional outcome after orthopedic management in a distal arthrogryposis cohort. Indirect because the cohort pools distal arthrogryposis types and does not report Gordon syndrome separately.
Dental management adapted to limited mouth opening
Action: dental careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is dental care, annotated with Dental Procedure (NCIT:C38052). NCIT:C38052 is a clinical intervention from the NCI Thesaurus. Ontology label: Dental Procedure NCIT:C38052
Platform: Other
Limited mouth opening and impaired manual dexterity make oral hygiene difficult; management relies on individualized home care and regular dental review, with extractions and restorations possible under local anaesthesia.
Target Phenotypes: Limited mouth opening HP:0000211 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Limited mouth opening, annotated with Trismus (HP:0000211). HP:0000211 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:34038001 SUPPORT Human Clinical
"Dental management should focus on ensuring that the patient is able to maintain good oral hygiene by customising homecare for the individual and regular dental visits."
Dental management recommendations for Gordon syndrome.
🔬

Diagnosis

2
Prenatal ultrasound with genetic testing
Contractures and clubfoot can be seen on fetal ultrasound, from as early as 13 weeks of gestation in one family, and the diagnosis is confirmed by finding a heterozygous PIEZO2 variant.
fetal ultrasound NCIT:C17230 NCI Thesaurus (NCIT)
Show evidence (2 references)
PMID:37587573 SUPPORT Human Clinical
"A prenatal diagnosis of GS can be established by fetal ultrasound examination combined with genetic testing."
States the prenatal diagnostic approach.
PMID:27714920 SUPPORT Human Clinical
"a male neonate showing typical signs of arthrogryposis in the prenatal ultrasound examination already seen at 13 week of gestation"
Arthrogryposis visible on first-trimester ultrasound.
PIEZO2 sequencing
Exome or targeted sequencing of PIEZO2. Most families carry c.8057G>A (p.Arg2686His), but in a minority of clinically diagnosed families no PIEZO2 variant was found.
exome sequencing NCIT:C101295 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:24726473 SUPPORT Human Clinical
"Sanger sequencing revealed PIEZO2 mutations in five of seven additional families studied (for a total of 10/12 [83%] individuals), and nine families had an identical c.8057G>A (p.Arg2686His) mutation."
Yield of PIEZO2 sequencing in clinically diagnosed families.
📊

Prevalence

1
Worldwide
Point Prevalence Not yet documented
Orphanet records the worldwide point prevalence class as unknown. The literature consists of a small number of families; a 1981 report described the condition as known from only three previously described families.
Show evidence (2 references)
ORPHA:376 SUPPORT Other
"Unknown | Worldwide | Point prevalence | ORPHANET"
Orphanet epidemiology table gives no prevalence estimate.
PMID:7258227 SUPPORT Human Clinical
"The triad of a camptodactyly, club feet, and cleft palate, called the Gordon syndrome, is a rare autosomal dominant trait with variable expressivity, known from only three previously described families."
The small number of reported families at the time illustrates the rarity of the condition.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from Gordon Syndrome:

Distal arthrogryposis type 5 Not Yet Curated MONDO:0007158
Overlapping Features Allelic PIEZO2 disorder with contractures plus ophthalmoplegia and restrictive lung disease. Its distinction from Gordon syndrome is less clear than that of Marden-Walker syndrome, and both may be variable expressions of one condition.
Show evidence (2 references)
PMID:36588752 SUPPORT Human Clinical
"Out of these, MWS has a recognizable phenotype that can be discerned easily, but the distinction between GS and DA5 is less evident."
Gordon syndrome and DA5 are hard to separate clinically.
PMID:41572728 SUPPORT Human Clinical
"A review of individuals with the same PIEZO2 variant demonstrates marked phenotypic variability-from Gordon syndrome to distal arthrogryposis type 5-underscoring allelic heterogeneity and variable expressivity."
Carriers of one PIEZO2 variant range from Gordon syndrome to DA5, so the clinical label does not map one-to-one onto the allele.
Overlapping Features Severe end of the dominant PIEZO2 spectrum, with mask-like face, blepharophimosis, developmental delay and multiple contractures; also genetically heterogeneous.
Show evidence (1 reference)
PMID:24726473 SUPPORT Human Clinical
"Collectively, although GS, DA5, and MWS have traditionally been considered separate disorders, our findings indicate that they are etiologically related and perhaps represent variable expressivity of the same condition."
Places Marden-Walker syndrome on the same etiological spectrum.
Arthrogryposis, distal, with impaired proprioception and touch Not Yet Curated MONDO:0014941
Overlapping Features Recessive PIEZO2 loss-of-function disorder: arthrogryposis with muscular atrophy, scoliosis, progressive contractures and loss of proprioception and touch. Same gene, opposite channel effect and inheritance.
Show evidence (1 reference)
PMID:27607563 SUPPORT Human Clinical
"Recessive mutations in PIEZO2 thus appear to cause a progressive phenotype that overlaps with, while being mostly distinct from that associated with dominant mutations in the same gene."
Distinguishes the recessive loss-of-function phenotype from the dominant one.
Aase-Smith syndrome Not Yet Curated MONDO:0007839
Overlapping Features Distal arthrogryposis with cleft palate; one family showed clinical overlap with Gordon syndrome.
Show evidence (1 reference)
PMID:11152147 SUPPORT Human Clinical
"We report a family with distal arthrogryposis and cleft palate which demonstrates the clinical overlap between Gordon syndrome and Aase-Smith syndrome."
Documents clinical overlap with Aase-Smith syndrome.
🐁

Animal Models

1
Gain-of-function Piezo2 E2799del knock-in mouse
Mouse carrying the mouse equivalent of the human distal arthrogryposis type 5 variant E2727del, expressed constitutively or restricted by Cre driver to proprioceptive neurons (Pvalb), all sensory neurons (Advillin, inducible) or limb mesenchyme (Prrx1). Constitutive and proprioceptor-restricted mice develop hindlimb contractures and shortened tendons; mesenchyme-restricted mice do not. Botulinum toxin injected into the hindlimb at postnatal days 7 to 10, or a maternal diet enriched in eicosapentaenoic acid, which shortens PIEZO2 inactivation, reduced the defects.
Species
Mouse
Genotype
Piezo2 E2799del (equivalent of human PIEZO2 E2727del), Cre-dependent knock-in, heterozygous
Publication
{ }

Source YAML

click to show
name: Gordon Syndrome
creation_date: "2026-10-14T20:49:40Z"
category: Mendelian
description: >-
  Gordon syndrome (distal arthrogryposis type 3, DA3) is a rare autosomal
  dominant multiple congenital malformation syndrome defined by congenital
  contractures of the hands and feet, chiefly camptodactyly and clubfoot, with
  cleft palate in a minority of affected people. Short stature, scoliosis,
  ptosis, micrognathia, pectus excavatum and cryptorchidism occur in some
  individuals, and intelligence is usually normal. Penetrance is reduced and
  expressivity variable, with more reduced penetrance in females. Gordon
  syndrome is caused by heterozygous variants in PIEZO2, which encodes the
  principal mechanically activated cation channel of proprioceptive and touch
  sensory neurons; most families carry the recurrent c.8057G>A (p.Arg2686His)
  variant, which is significantly associated with cleft palate. The dominant
  PIEZO2 variants studied electrophysiologically make the channel recover
  faster from inactivation, increasing channel activity for a given mechanical
  stimulus, and a mouse carrying such a gain-of-function allele in
  proprioceptive sensory neurons develops shortened tendons and joint
  contractures. Gordon syndrome is allelic with distal arthrogryposis type 5
  and Marden-Walker syndrome, which McMillin et al. regard as possibly variable
  expressions of one PIEZO2-related condition.
synonyms:
- Gordon syndrome
- distal arthrogryposis type 3
- arthrogryposis, distal, type 3
- DA3
- distal arthrogryposis type IIA
- camptodactyly-cleft palate-clubfoot syndrome
parents:
- distal arthrogryposis
- multiple congenital anomalies/dysmorphic syndrome without intellectual disability
disease_term:
  preferred_term: Gordon syndrome
  term:
    id: MONDO:0007252
    label: Gordon syndrome
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
references:
- reference: PMID:24726473
  title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
- reference: PMID:36634173
  title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
- reference: ORPHA:376
  title: "Gordon syndrome"
inheritance:
- name: Autosomal dominant inheritance with reduced penetrance
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  penetrance: INCOMPLETE
  expressivity: VARIABLE
  description: >-
    Gordon syndrome segregates as an autosomal dominant trait in multigeneration
    families, with reduced penetrance and variable expressivity. Penetrance is
    lower in females than in males, and in one five-generation family every
    asymptomatic carrier was female. A probably de novo PIEZO2 variant has been
    reported in a fetus of unaffected parents, in whom parental germline
    mosaicism could not be excluded.
  evidence:
  - reference: PMID:24726473
    reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Gordon syndrome (GS), or distal arthrogryposis type 3, is a rare, autosomal-dominant disorder characterized by cleft palate and congenital contractures of the hands and feet."
    explanation: >-
      The gene-discovery study describes Gordon syndrome as an autosomal
      dominant disorder.
  - reference: PMID:458832
    reference_title: "Camptodactyly, cleft palate, and club foot (the Gordon syndrome). A report of a large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A second family is described in which camptodactyly, club foot, and cleft palate (the Gordon syndrome) is transmitted in a pattern consistent with autosomal dominant inheritance with reduced penetrance and variable expressivity."
    explanation: >-
      A large pedigree shows autosomal dominant transmission with reduced
      penetrance and variable expressivity.
  - reference: PMID:8370149
    reference_title: "Distal arthrogryposis with autosomal dominant inheritance and reduced penetrance in females: the Gordon syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Penetrance is more reduced in females than in males and asymptomatic carriers are always females."
    explanation: >-
      A five-generation family shows the sex difference in penetrance: all
      asymptomatic carriers were female.
  - reference: PMID:37587573
    reference_title: "A novel PIEZO2 mutation in a fetus from a Chinese family with Gordon syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sanger sequencing of the proband's parents resulted in normal chromatograms, suggesting that this was either a de novo variant in the fetus or, less likely, the result of germline mosaicism in the proband's mother or father."
    explanation: >-
      Documents a probable de novo occurrence in a simplex fetus, alongside
      the familial dominant transmission seen in most reports.
prevalence:
- population: Worldwide
  measure_type: POINT_PREVALENCE
  prevalence_class: NOT_YET_DOCUMENTED
  notes: >-
    Orphanet records the worldwide point prevalence class as unknown. The
    literature consists of a small number of families; a 1981 report
    described the condition as known from only three previously described
    families.
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Unknown | Worldwide | Point prevalence | ORPHANET"
    explanation: Orphanet epidemiology table gives no prevalence estimate.
  - reference: PMID:7258227
    reference_title: "The Gordon syndrome: autosomal dominant cleft palate, camptodactyly, and club feet."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The triad of a camptodactyly, club feet, and cleft palate, called the Gordon syndrome, is a rare autosomal dominant trait with variable expressivity, known from only three previously described families."
    explanation: >-
      The small number of reported families at the time illustrates the
      rarity of the condition.
genetic:
- name: PIEZO2
  gene_term:
    preferred_term: PIEZO2
    term:
      id: hgnc:26270
      label: PIEZO2
  association: Causative (heterozygous, dominant)
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    PIEZO2 encodes a large mechanically activated non-selective cation channel,
    the principal mechanotransducer for proprioception and light touch. In the
    gene-discovery study PIEZO2 variants were found in all five exome-sequenced
    Gordon syndrome families and in five of seven further families, and nine
    families shared c.8057G>A (p.Arg2686His). Dominant PIEZO2 variants
    cluster toward the C-terminal region, whereas the recessive variants that
    cause a different, loss-of-function disorder cluster toward the N-terminal
    region. The same gene causes distal arthrogryposis type 5 and a subset of
    Marden-Walker syndrome.
  evidence:
  - reference: PMID:24726473
    reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family."
    explanation: Identifies PIEZO2 as the Gordon syndrome gene.
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In all affected family members, we identified the PIEZO2 mutation c.8057G>A (p.Arg2686His) by Sanger sequencing."
    explanation: >-
      Independent replication in a three-generation family with the recurrent
      variant segregating with disease.
  - reference: PMID:28728825
    reference_title: "Genetic Diseases of PIEZO1 and PIEZO2 Dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: "Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis."
    explanation: >-
      A review places the dominant distal arthrogryposes, of which Gordon
      syndrome is one, under PIEZO2 gain of function.
  - reference: PMID:30988732
    reference_title: "Mutations in PIEZO2 contribute to Gordon syndrome, Marden-Walker syndrome and distal arthrogryposis: A bioinformatics analysis of mechanisms."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "Dominant mutations were mainly located in the C-terminal region, whereas recessive mutations were mainly localized in the N-terminal region"
    explanation: >-
      Supports the positional split between dominant (Gordon/DA5/MWS) and
      recessive PIEZO2 variants.
  variants:
  - name: PIEZO2 c.8057G>A (p.Arg2686His)
    clinical_significance: PATHOGENIC
    description: >-
      The recurrent Gordon syndrome variant, shared by nine families in the
      gene-discovery series and reported independently in a three-generation
      family and in a girl with Gordon syndrome and Dandy-Walker malformation.
      Cleft palate is significantly associated with this variant. The cited
      sources do not report a patch-clamp characterization of this specific
      variant; its gain-of-function action is inferred from the
      electrophysiology of other dominant PIEZO2 variants.
    evidence:
    - reference: PMID:24726473
      reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Sanger sequencing revealed PIEZO2 mutations in five of seven additional families studied (for a total of 10/12 [83%] individuals), and nine families had an identical c.8057G>A (p.Arg2686His) mutation."
      explanation: Establishes p.Arg2686His as the recurrent Gordon syndrome variant.
    - reference: PMID:24726473
      reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The presence of cleft palate was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001)."
      explanation: Genotype-phenotype association between this variant and cleft palate.
    - reference: PMID:36588752
      reference_title: "Further Evidence of a Continuum in the Clinical Spectrum of Dominant PIEZO2-Related Disorders and Implications in Cerebellar Anomalies."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In addition, another girl with the typical clinical features of GS is also described carrying the most prevalent reported variant (c.8057G>A, p.R2686H) in PIEZO2."
      explanation: Further report of the recurrent variant in typical Gordon syndrome.
  - name: PIEZO2 c.8576G>A (p.Trp2859*)
    clinical_significance: UNCERTAIN_SIGNIFICANCE
    description: >-
      A heterozygous nonsense variant in exon 56, classified by the reporting
      authors as of uncertain significance, found in a fetus with clubfoot,
      camptodactyly, micrognathia and cleft palate and absent from both
      parents. Its effect on the channel has not been tested.
    evidence:
    - reference: PMID:37587573
      reference_title: "A novel PIEZO2 mutation in a fetus from a Chinese family with Gordon syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Whole-exome sequencing revealed that the fetus was heterozygous for a novel variant of uncertain significance in exon 56 (c.8576G>A; p.Trp2859*) of the Piezo-type mechanosensitive ion channel component 2 gene (PIEZO2) (NM_001378183.1)."
      explanation: Reports the variant, its location and its uncertain-significance classification.
pathophysiology:
- name: PIEZO2 Gain-of-Function and Mechanotransduction Defect
  biological_scale: MOLECULAR
  role: trigger
  mechanism_confidence: ESTABLISHED
  description: >-
    Heterozygous dominant PIEZO2 variants alter the kinetics of the
    mechanically activated channel rather than abolishing it. The dominant
    variants characterized by patch clamp (E2727del and I802F, from distal
    arthrogryposis type 5 families) make PIEZO2-dependent currents recover
    faster from inactivation, and E2727del also slows inactivation, so the
    channel passes more current for a given mechanical stimulus. Mutant
    channels are not constitutively open and are not toxic to cells. The
    recurrent Gordon syndrome variant p.Arg2686His is treated as acting the
    same way by inference from these alleles. The node name is shared with the
    Marden-Walker syndrome entry because the lesion is the same.
  genes:
  - preferred_term: PIEZO2
    term:
      id: hgnc:26270
      label: PIEZO2
  genetic_context:
    functional_impact_category: GAIN_OF_FUNCTION
    variant_origin: GERMLINE
    zygosity: HETEROZYGOUS
    description: >-
      Heterozygous germline variants, most often c.8057G>A (p.Arg2686His).
  molecular_functions:
  - preferred_term: mechanosensitive cation channel activity
    term:
      id: GO:0008381
      label: mechanosensitive monoatomic ion channel activity
    modifier: INCREASED
  biological_processes:
  - preferred_term: detection of mechanical stimulus
    term:
      id: GO:0050982
      label: detection of mechanical stimulus
    modifier: INCREASED
  evidence:
  - reference: PMID:23487782
    reference_title: "Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: IN_VITRO
    snippet: "both E2727del and I802F mutations cause the PIEZO2-dependent, mechanically activated currents to recover faster from inactivation, while E2727del also causes a slowing of inactivation."
    explanation: >-
      Patch-clamp characterization of two dominant PIEZO2 variants. Indirect
      for Gordon syndrome because the alleles come from distal arthrogryposis
      type 5 families.
  - reference: PMID:23487782
    reference_title: "Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: IN_VITRO
    snippet: "We further show that overexpression of mutated PIEZO2 cDNAs does not cause constitutive activity or toxicity to cells, indicating that the observed phenotype is likely due to a mechanotransduction defect."
    explanation: >-
      Shows the defect is altered mechanotransduction rather than constitutive
      opening or cytotoxicity.
  - reference: PMID:27843126
    reference_title: "Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "In contrast, heterozygous gain-of-function missense mutations, mainly localized at the C terminus, cause dominant distal arthrogryposis 3 (DA3), distal arthrogryposis 5 (DA5), or Marden-Walker syndrome (MWKS), which encompass contractures of hands and feet, scoliosis, ophthalmoplegia, and ptosis."
    explanation: >-
      States that DA3 (Gordon syndrome) is caused by heterozygous
      gain-of-function C-terminal PIEZO2 missense variants.
  downstream:
  - target: Excessive Mechanotransduction in Proprioceptive Sensory Neurons
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:36634173
      reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "They also demonstrate that heterozygosity of GOF PIEZO2 is sufficient to increase mechanosensitivity in sensory neurons."
      explanation: >-
        In knock-in mice, one copy of a gain-of-function Piezo2 allele is
        enough to raise mechanosensitivity in sensory neurons. Indirect because
        the allele modelled is a distal arthrogryposis type 5 variant.
  - target: Incomplete Secondary Palate Fusion
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Cleft palate is associated with the recurrent p.Arg2686His variant. The
      developmental route from PIEZO2 gain of function to failed palatal
      closure is not described in the cited sources.
    evidence:
    - reference: PMID:24726473
      reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The presence of cleft palate was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001)."
      explanation: >-
        Allele-specific association between the Gordon syndrome variant and
        cleft palate.
  - target: Ptosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Ptosis is reported across the dominant PIEZO2 spectrum; the mechanism
      linking PIEZO2 gain of function to eyelid and extraocular involvement is
      not established.
    evidence:
    - reference: PMID:27843126
      reference_title: "Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: BACKGROUND
      snippet: "In contrast, heterozygous gain-of-function missense mutations, mainly localized at the C terminus, cause dominant distal arthrogryposis 3 (DA3), distal arthrogryposis 5 (DA5), or Marden-Walker syndrome (MWKS), which encompass contractures of hands and feet, scoliosis, ophthalmoplegia, and ptosis."
      explanation: >-
        Names ptosis among the features of the dominant PIEZO2 disorders,
        including DA3.
  - target: Dandy-Walker malformation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Posterior fossa malformation in PIEZO2-positive patients suggests a role
      for PIEZO2 in hindbrain development; the mechanism is unknown and the
      association rests on few cases.
    evidence:
    - reference: PMID:36588752
      reference_title: "Further Evidence of a Continuum in the Clinical Spectrum of Dominant PIEZO2-Related Disorders and Implications in Cerebellar Anomalies."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The association of DWM with arthrogryposis in the presence of PIEZO2 variants remains quite interesting and provides more evidence that PIEZO2 plays a role in the development of hindbrain although the underlying mechanism remains unclear."
      explanation: >-
        The authors connect PIEZO2 variants to hindbrain malformation while
        stating the mechanism is unclear.
- name: Incomplete Secondary Palate Fusion
  biological_scale: TISSUE
  role: consequence
  mechanism_confidence: PROVISIONAL
  description: >-
    Failure of the secondary palate to close completely, giving cleft palate
    or its minor form, bifid uvula. In Gordon syndrome this is the least often
    expressed element of the classic triad and is significantly associated
    with the recurrent p.Arg2686His variant. How altered PIEZO2
    mechanotransduction affects palatal shelf development is not known; the
    node is PROVISIONAL because the link to PIEZO2 is a genotype-phenotype
    association rather than a demonstrated mechanism.
  locations:
  - preferred_term: secondary palate
    term:
      id: UBERON:0001716
      label: secondary palate
  biological_processes:
  - preferred_term: secondary palate development
    term:
      id: GO:0062009
      label: secondary palate development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:24726473
    reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The presence of cleft palate was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001)."
    explanation: Allele-specific association with cleft palate.
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
    explanation: Bifid uvula or cleft palate in a PIEZO2-positive family.
  downstream:
  - target: Cleft palate
  - target: Bifid uvula
- name: Excessive Mechanotransduction in Proprioceptive Sensory Neurons
  biological_scale: CELLULAR
  role: central_effector
  mechanism_confidence: PROVISIONAL
  description: >-
    PIEZO2 is the principal mechanotransduction channel of proprioceptive
    sensory neurons, which innervate muscle spindles and tendon organs. In mice,
    expressing a gain-of-function Piezo2 allele only in these neurons is
    sufficient to reproduce the limb contractures, whereas expressing it only
    in limb mesenchyme (muscle, cartilage and tendon) is not. The effect
    depends on neuronal activity during a postnatal developmental window, and
    botulinum toxin, but not motor-endplate blockade with alpha-bungarotoxin,
    prevents it. The authors interpret this as an efferent action of the
    afferent nerve endings, likely through increased exocytosis, rather than
    increased reflex motor drive; stretch-evoked muscle spindle afferent firing
    was not increased ex vivo. The node is PROVISIONAL because the evidence
    is from a mouse carrying a distal arthrogryposis type 5 allele, not the
    Gordon syndrome variant.
  cell_types:
  - preferred_term: proprioceptive sensory neuron
    term:
      id: CL:1001451
      label: sensory neuron of dorsal root ganglion
  locations:
  - preferred_term: muscle spindle
    term:
      id: UBERON:0003718
      label: muscle spindle
  biological_processes:
  - preferred_term: detection of mechanical stimulus
    term:
      id: GO:0050982
      label: detection of mechanical stimulus
    modifier: INCREASED
  evidence:
  - reference: PMID:27843126
    reference_title: "Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "PIEZO2 encodes a mechanosensitive ion channel that plays a major role in light-touch mechanosensation and has recently been identified as the principal mechanotransduction channel for proprioception."
    explanation: Identifies the proprioceptive neuron as the main cellular site of PIEZO2 function.
  - reference: PMID:27184818
    reference_title: "A critical role for Piezo2 channels in the mechanotransduction of mouse proprioceptive neurons."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The data clearly shows that Piezo2 fulfills a critical role in a defined homogeneous population of proprioceptor neurons that innervate the head muscles, demonstrating that this ion channel is essential for mammalian proprioceptive mechanotransduction."
    explanation: >-
      Conditional deletion in mice shows PIEZO2 carries the mechanically
      activated current of proprioceptive neurons, the cell type whose
      overactivity this node describes.
  - reference: PMID:36634173
    reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "We show that expression of a gain-of-function PIEZO2 mutation in proprioceptive sensory neurons that mainly innervate muscle spindles and tendons is sufficient to induce DA5-like phenotypes in mice."
    explanation: >-
      Cell-type-restricted expression locates the pathogenic action in
      proprioceptive sensory neurons.
  - reference: PMID:36634173
    reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "Together, our pharmacological experiments suggest that GOF PIEZO2 causes musculoskeletal abnormalities via ectopic efferent activity in afferent peripheral mechanosensory neuronal endings, likely involving increased levels of exocytosis."
    explanation: >-
      The proposed cellular mechanism: efferent activity of the afferent
      endings, most likely increased exocytosis.
  - reference: PMID:36634173
    reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "This implies that motor activity does not play a major role in DA5 like deficits."
    explanation: >-
      Motor-endplate blockade did not rescue the defects, arguing against
      increased reflex motor drive as the route.
  - reference: PMID:36634173
    reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "We found that muscle spindle afferent activity in response to stretch is not significantly different between wild type and GOF Piezo2 mice at P7 postnatal stage"
    explanation: >-
      Afferent firing was unchanged, which is why the node is framed as excess
      mechanotransduction acting locally at the endings rather than as
      increased proprioceptive signalling.
  downstream:
  - target: Tendon Shortening and Disrupted Musculoskeletal Development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The signal released from overactive sensory endings that alters tendon
      and joint development has not been identified.
    evidence:
    - reference: PMID:36634173
      reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "Our study has identified a critical postnatal period during development when relatively small excess PIEZO2 activity in somatosensory neurons can cause tendon deficits and severe joint contractures."
      explanation: >-
        Links excess PIEZO2 activity in sensory neurons to tendon deficits
        during a developmental window.
- name: Tendon Shortening and Disrupted Musculoskeletal Development
  biological_scale: TISSUE
  role: central_effector
  mechanism_confidence: PROVISIONAL
  description: >-
    In gain-of-function Piezo2 mice the hindlimb tendons are shorter than in
    wild-type littermates, and the authors propose that shortened tendons
    produce the contractures. Proprioceptive nerve endings and muscle fiber
    diameters looked normal, so the defect is in tendon and joint development
    rather than in sensory-ending formation or muscle growth. Mouse-derived;
    tendon length has not been measured in people with Gordon syndrome in the
    cited sources.
  locations:
  - preferred_term: tendon
    term:
      id: UBERON:0000043
      label: tendon
  biological_processes:
  - preferred_term: tendon development
    term:
      id: GO:0035989
      label: tendon development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:36634173
    reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "we observed that the average length of tendons was significantly reduced in GOFconst. mice compared to wild type"
    explanation: Measured tendon shortening in the gain-of-function mouse.
  downstream:
  - target: Congenital Distal Joint Contractures
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:36634173
      reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "It is therefore possible that the DA5-like contractures are caused by shortened tendons."
      explanation: >-
        The authors propose tendon shortening as the cause of the contractures;
        stated as a possibility, not demonstrated.
- name: Congenital Distal Joint Contractures
  biological_scale: TISSUE
  role: consequence
  mechanism_confidence: ESTABLISHED
  description: >-
    The defining lesion: fixed contractures present from birth, chiefly at the
    finger joints (camptodactyly) and feet (clubfoot), sometimes extending to
    elbows, shoulders, knees and ankles. Contractures can be detected on
    prenatal ultrasound from the first trimester. The spinal curve seen in some
    patients has the characteristics of an arthrogrypotic neuromuscular curve.
  locations:
  - preferred_term: hand
    term:
      id: UBERON:0002398
      label: manus
  - preferred_term: foot
    term:
      id: UBERON:0002387
      label: pes
  evidence:
  - reference: PMID:24726473
    reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Gordon syndrome (GS), or distal arthrogryposis type 3, is a rare, autosomal-dominant disorder characterized by cleft palate and congenital contractures of the hands and feet."
    explanation: Congenital hand and foot contractures define the disorder.
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
    explanation: Documents distal and large-joint contractures in a PIEZO2-positive family.
  - reference: PMID:36634173
    reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "We observed that hindlimbs of the transgenic mice had contractures compared to wild type littermates"
    explanation: The gain-of-function mouse reproduces distal limb contractures.
  downstream:
  - target: Distal arthrogryposis
  - target: Camptodactyly of fingers
  - target: Clubfoot
  - target: Large-joint contractures
  - target: Scoliosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:11718203
      reference_title: "Scoliosis in Gordon's syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Scoliosis in Gordon's Syndrome shares the characteristics of an arthrogrypotic neuromuscular curve and demands extensive soft tissue release for optimal correction."
      explanation: >-
        Characterizes the spinal curve as arthrogrypotic, placing it downstream
        of the contracture process.
phenotypes:
- category: Musculoskeletal
  name: Distal arthrogryposis
  description: >-
    Congenital contractures of the hands and feet, the defining feature of the
    disorder.
  phenotype_term:
    preferred_term: Distal arthrogryposis
    term:
      id: HP:0005684
      label: Distal arthrogryposis
  evidence:
  - reference: PMID:24726473
    reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Gordon syndrome (GS), or distal arthrogryposis type 3, is a rare, autosomal-dominant disorder characterized by cleft palate and congenital contractures of the hands and feet."
    explanation: Defines the disorder by congenital hand and foot contractures.
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Gordon syndrome, also known as distal arthrogryposis type 3, is an extremely rare multiple congenital malformation syndrome characterized by congenital contractures of hand and feet with variable degrees of severity of camptodactyly, clubfoot and, less frequently, cleft palate."
    explanation: Orphanet definition of the disorder.
- category: Musculoskeletal
  name: Camptodactyly of fingers
  description: >-
    Fixed flexion contractures of the fingers, present in most affected people.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Camptodactyly of finger
    term:
      id: HP:0100490
      label: Camptodactyly of finger
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0100490 | Camptodactyly of finger | Very frequent (99-80%)"
    explanation: Orphanet grades camptodactyly as very frequent.
  - reference: PMID:11718203
    reference_title: "Scoliosis in Gordon's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "Gordon's Syndrome is described as an autosomal dominant condition with the characteristics of short stature, a stiff spine, camptodactyly (89%), cleft palate (27%) and club feet (73%)."
    explanation: Literature-derived frequency of camptodactyly (89%).
- category: Musculoskeletal
  name: Clubfoot
  description: >-
    Congenital clubfoot. A literature summary gives 73%; Orphanet grades talipes
    as very frequent. The lower literature figure is used for the frequency.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Clubfoot
    term:
      id: HP:0001762
      label: Talipes equinovarus
  evidence:
  - reference: PMID:11718203
    reference_title: "Scoliosis in Gordon's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "Gordon's Syndrome is described as an autosomal dominant condition with the characteristics of short stature, a stiff spine, camptodactyly (89%), cleft palate (27%) and club feet (73%)."
    explanation: Literature-derived frequency of club feet (73%).
  - reference: PMID:37587573
    reference_title: "A novel PIEZO2 mutation in a fetus from a Chinese family with Gordon syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe a fetus from a Chinese family whose parents were both healthy but showed multiple malformations, including clubfoot, camptodactyly, micrognathia, and cleft palate."
    explanation: Clubfoot in a PIEZO2-positive fetus.
- category: Musculoskeletal
  name: Large-joint contractures
  description: >-
    Contractures beyond the hands and feet, at the elbows, shoulders, knees and
    ankles, are reported in some families.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Limitation of joint mobility
    term:
      id: HP:0001376
      label: Limitation of joint mobility
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0001376 | Limitation of joint mobility | Occasional (29-5%)"
    explanation: Orphanet grades limitation of joint mobility as occasional.
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
    explanation: Elbow, shoulder, knee and ankle contractures in a PIEZO2-positive family.
- category: Musculoskeletal
  name: Scoliosis
  description: >-
    Scoliosis or a stiff spine, which can become a complex deformity requiring
    surgery.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0002650 | Scoliosis | Occasional (29-5%)"
    explanation: Orphanet grades scoliosis as occasional.
  - reference: PMID:11718203
    reference_title: "Scoliosis in Gordon's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The authors present a case report of a patient with this rare entity complicated by an unusual complex spinal deformity."
    explanation: Case report of complex spinal deformity in Gordon syndrome.
- category: Craniofacial
  name: Cleft palate
  description: >-
    Cleft palate, the least often expressed element of the classic triad, is
    significantly associated with the recurrent p.Arg2686His variant.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000175 | Cleft palate | Occasional (29-5%)"
    explanation: Orphanet grades cleft palate as occasional.
  - reference: PMID:11718203
    reference_title: "Scoliosis in Gordon's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "Gordon's Syndrome is described as an autosomal dominant condition with the characteristics of short stature, a stiff spine, camptodactyly (89%), cleft palate (27%) and club feet (73%)."
    explanation: Literature-derived frequency of cleft palate (27%).
  - reference: PMID:458832
    reference_title: "Camptodactyly, cleft palate, and club foot (the Gordon syndrome). A report of a large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Penetrance appears to be more reduced in females than in males, and cleft palate is the least frequently manifested trait."
    explanation: Cleft palate is the least often expressed component in a large pedigree.
- category: Craniofacial
  name: High palate
  description: >-
    A high-arched palate, reported more often than overt clefting.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: High palate
    term:
      id: HP:0000218
      label: High palate
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000218 | High palate | Frequent (79-30%)"
    explanation: Orphanet grades high palate as frequent.
- category: Craniofacial
  name: Bifid uvula
  description: >-
    Bifid uvula, a minor form of palatal clefting, reported with cleft palate in
    a PIEZO2-positive family.
  phenotype_term:
    preferred_term: Bifid uvula
    term:
      id: HP:0000193
      label: Bifid uvula
  evidence:
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
    explanation: Reports bifid uvula or cleft palate in the family.
- category: Craniofacial
  name: Micrognathia
  description: >-
    Small mandible, noted in some individuals and detected prenatally.
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: PMID:37587573
    reference_title: "A novel PIEZO2 mutation in a fetus from a Chinese family with Gordon syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe a fetus from a Chinese family whose parents were both healthy but showed multiple malformations, including clubfoot, camptodactyly, micrognathia, and cleft palate."
    explanation: Micrognathia in a PIEZO2-positive fetus.
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Intelligence is normal but in some cases, additional abnormalities, such as short stature, kyphoscoliosis, ptosis, micrognathia, and cryptorchidism may also be present."
    explanation: Orphanet lists micrognathia among the variable additional features.
- category: Craniofacial
  name: Limited mouth opening
  description: >-
    Restricted mouth opening, which complicates dental care; in one reported
    adolescent it was accompanied by enlarged coronoid processes of the
    mandible.
  phenotype_term:
    preferred_term: Limited mouth opening
    term:
      id: HP:0000211
      label: Trismus
  evidence:
  - reference: PMID:34038001
    reference_title: "Gordon syndrome: Dental implications and a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He had a significant limitation of mouth opening (2 cm at incisors)."
    explanation: Documents restricted mouth opening in a patient with Gordon syndrome.
- category: Ophthalmologic
  name: Ptosis
  description: >-
    Drooping of the upper eyelid, present in some individuals.
  phenotype_term:
    preferred_term: Ptosis
    term:
      id: HP:0000508
      label: Ptosis
  evidence:
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here, we present a family with three affected individuals exhibiting multiple contractures (metacarpo-phalangeal and interphalangeal joints as well as elbow, shoulder, knee, and ankle joints), clubfeet, short stature, bifid uvula/cleft palate, and a distinct facial phenotype including ptosis."
    explanation: Ptosis in a PIEZO2-positive family.
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Intelligence is normal but in some cases, additional abnormalities, such as short stature, kyphoscoliosis, ptosis, micrognathia, and cryptorchidism may also be present."
    explanation: Orphanet lists ptosis among the variable additional features.
- category: Growth
  name: Short stature
  description: >-
    Short stature, which with cleft palate distinguishes Gordon syndrome from
    other distal arthrogryposes.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0004322 | Short stature | Occasional (29-5%)"
    explanation: Orphanet grades short stature as occasional.
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It is distinguishable from other forms of distal arthrogryposis by cleft palate and short stature."
    explanation: Short stature as a distinguishing feature.
- category: Musculoskeletal
  name: Pectus excavatum
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Pectus excavatum
    term:
      id: HP:0000767
      label: Pectus excavatum
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000767 | Pectus excavatum | Occasional (29-5%)"
    explanation: Orphanet grades pectus excavatum as occasional.
  - reference: PMID:8370149
    reference_title: "Distal arthrogryposis with autosomal dominant inheritance and reduced penetrance in females: the Gordon syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A family is reported in which camptodactyly, club foot, pectus excavatum and undescended testes are transmitted as an autosomal dominant with reduced penetrance and variable expressivity, affecting 13 members through five generations."
    explanation: Pectus excavatum segregating in a five-generation family.
- category: Genitourinary
  name: Cryptorchidism
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Cryptorchidism
    term:
      id: HP:0000028
      label: Cryptorchidism
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000028 | Cryptorchidism | Occasional (29-5%)"
    explanation: Orphanet grades cryptorchidism as occasional.
  - reference: PMID:8370149
    reference_title: "Distal arthrogryposis with autosomal dominant inheritance and reduced penetrance in females: the Gordon syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A family is reported in which camptodactyly, club foot, pectus excavatum and undescended testes are transmitted as an autosomal dominant with reduced penetrance and variable expressivity, affecting 13 members through five generations."
    explanation: Undescended testes segregating in a five-generation family.
- category: Musculoskeletal
  name: Decreased muscle mass
  description: >-
    Reduced muscle bulk. In the gain-of-function mouse, muscle fiber diameters
    were normal, so this feature is not attached to the sensory-neuron chain.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Decreased muscle mass
    term:
      id: HP:0003199
      label: Decreased muscle mass
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0003199 | Decreased muscle mass | Frequent (79-30%)"
    explanation: Orphanet grades decreased muscle mass as frequent.
- category: Otolaryngologic
  name: Hearing impairment
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: ORPHA:376
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000365 | Hearing impairment | Occasional (29-5%)"
    explanation: Orphanet grades hearing impairment as occasional.
- category: Neurologic
  name: Dandy-Walker malformation
  description: >-
    Posterior fossa malformation reported in a girl with typical Gordon
    syndrome and the recurrent p.Arg2686His variant, as in some individuals
    with Marden-Walker syndrome. A single case, so no frequency is given.
  phenotype_term:
    preferred_term: Dandy-Walker malformation
    term:
      id: HP:0001305
      label: Dandy-Walker malformation
  evidence:
  - reference: PMID:36588752
    reference_title: "Further Evidence of a Continuum in the Clinical Spectrum of Dominant PIEZO2-Related Disorders and Implications in Cerebellar Anomalies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The brain MRI of the 2 patients showed Dandy-Walker malformation (DWM)."
    explanation: >-
      One of the two patients with Dandy-Walker malformation had typical
      Gordon syndrome with p.Arg2686His.
- category: Neurologic
  name: Mild intellectual disability
  description: >-
    Intelligence is usually normal. Mild intellectual disability and
    psychomotor delay were reported in one three-generation family carrying
    p.Arg2686His, whose authors suggest it may belong to the phenotypic
    spectrum. Recorded with a contrary item because the Orphanet definition
    states that intelligence is normal.
  phenotype_term:
    preferred_term: Mild intellectual disability
    term:
      id: HP:0001256
      label: Mild intellectual disability
  evidence:
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our analysis indicated that mild delay in psychomotor development and intellectual disability could be part of the phenotypic spectrum of Gordon syndrome."
    explanation: Mild intellectual disability in one PIEZO2-positive family.
  - reference: ORPHA:376
    supports: REFUTE
    evidence_source: OTHER
    snippet: "Intelligence is normal but in some cases, additional abnormalities, such as short stature, kyphoscoliosis, ptosis, micrognathia, and cryptorchidism may also be present."
    explanation: Orphanet describes intelligence as normal in Gordon syndrome.
diagnosis:
- name: Prenatal ultrasound with genetic testing
  description: >-
    Contractures and clubfoot can be seen on fetal ultrasound, from as early as
    13 weeks of gestation in one family, and the diagnosis is confirmed by
    finding a heterozygous PIEZO2 variant.
  diagnosis_term:
    preferred_term: fetal ultrasound
    term:
      id: NCIT:C17230
      label: Ultrasound Imaging
  evidence:
  - reference: PMID:37587573
    reference_title: "A novel PIEZO2 mutation in a fetus from a Chinese family with Gordon syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A prenatal diagnosis of GS can be established by fetal ultrasound examination combined with genetic testing."
    explanation: States the prenatal diagnostic approach.
  - reference: PMID:27714920
    reference_title: "Familial Gordon syndrome associated with a PIEZO2 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a male neonate showing typical signs of arthrogryposis in the prenatal ultrasound examination already seen at 13 week of gestation"
    explanation: Arthrogryposis visible on first-trimester ultrasound.
- name: PIEZO2 sequencing
  description: >-
    Exome or targeted sequencing of PIEZO2. Most families carry c.8057G>A
    (p.Arg2686His), but in a minority of clinically diagnosed families no
    PIEZO2 variant was found.
  diagnosis_term:
    preferred_term: exome sequencing
    term:
      id: NCIT:C101295
      label: Whole Exome Sequencing
  evidence:
  - reference: PMID:24726473
    reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sanger sequencing revealed PIEZO2 mutations in five of seven additional families studied (for a total of 10/12 [83%] individuals), and nine families had an identical c.8057G>A (p.Arg2686His) mutation."
    explanation: Yield of PIEZO2 sequencing in clinically diagnosed families.
differential_diagnoses:
- name: Distal arthrogryposis type 5
  description: >-
    Allelic PIEZO2 disorder with contractures plus ophthalmoplegia and
    restrictive lung disease. Its distinction from Gordon syndrome is less
    clear than that of Marden-Walker syndrome, and both may be variable
    expressions of one condition.
  disease_term:
    preferred_term: distal arthrogryposis type 5
    term:
      id: MONDO:0007158
      label: arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
  evidence:
  - reference: PMID:36588752
    reference_title: "Further Evidence of a Continuum in the Clinical Spectrum of Dominant PIEZO2-Related Disorders and Implications in Cerebellar Anomalies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Out of these, MWS has a recognizable phenotype that can be discerned easily, but the distinction between GS and DA5 is less evident."
    explanation: Gordon syndrome and DA5 are hard to separate clinically.
  - reference: PMID:41572728
    reference_title: "Expanding the Genotype-Phenotype Correlation of Marden-Walker Syndrome due to PIEZO2 Gene Variants: A Case Report From Brazil."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A review of individuals with the same PIEZO2 variant demonstrates marked phenotypic variability-from Gordon syndrome to distal arthrogryposis type 5-underscoring allelic heterogeneity and variable expressivity."
    explanation: >-
      Carriers of one PIEZO2 variant range from Gordon syndrome to DA5, so the
      clinical label does not map one-to-one onto the allele.
- name: Marden-Walker syndrome
  description: >-
    Severe end of the dominant PIEZO2 spectrum, with mask-like face,
    blepharophimosis, developmental delay and multiple contractures; also
    genetically heterogeneous.
  disease_term:
    preferred_term: Marden-Walker syndrome
    term:
      id: MONDO:0009564
      label: Marden-Walker syndrome
  evidence:
  - reference: PMID:24726473
    reference_title: "Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Collectively, although GS, DA5, and MWS have traditionally been considered separate disorders, our findings indicate that they are etiologically related and perhaps represent variable expressivity of the same condition."
    explanation: Places Marden-Walker syndrome on the same etiological spectrum.
- name: Arthrogryposis, distal, with impaired proprioception and touch
  description: >-
    Recessive PIEZO2 loss-of-function disorder: arthrogryposis with muscular
    atrophy, scoliosis, progressive contractures and loss of proprioception and
    touch. Same gene, opposite channel effect and inheritance.
  disease_term:
    preferred_term: distal arthrogryposis with impaired proprioception and touch
    term:
      id: MONDO:0014941
      label: arthrogryposis, distal, with impaired proprioception and touch
  evidence:
  - reference: PMID:27607563
    reference_title: "Loss of the proprioception and touch sensation channel PIEZO2 in siblings with a progressive form of contractures."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Recessive mutations in PIEZO2 thus appear to cause a progressive phenotype that overlaps with, while being mostly distinct from that associated with dominant mutations in the same gene."
    explanation: Distinguishes the recessive loss-of-function phenotype from the dominant one.
- name: Aase-Smith syndrome
  description: >-
    Distal arthrogryposis with cleft palate; one family showed clinical overlap
    with Gordon syndrome.
  disease_term:
    preferred_term: Aase-Smith syndrome
    term:
      id: MONDO:0007839
      label: Aase-Smith syndrome
  evidence:
  - reference: PMID:11152147
    reference_title: "A family with distal arthrogryposis and cleft palate: possible overlap between Gordon syndrome and Aase-Smith syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report a family with distal arthrogryposis and cleft palate which demonstrates the clinical overlap between Gordon syndrome and Aase-Smith syndrome."
    explanation: Documents clinical overlap with Aase-Smith syndrome.
treatments:
- name: Orthopedic surgery for contractures and spinal deformity
  description: >-
    Surgical correction of clubfoot and contractures, and of scoliosis when
    present. The spinal curve behaves like an arthrogrypotic neuromuscular
    curve and needs extensive soft tissue release for correction. No
    disease-specific therapy exists.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: orthopedic surgical procedure
    term:
      id: NCIT:C16186
      label: Orthopedic Surgical Procedure
  target_phenotypes:
  - preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: PMID:11718203
    reference_title: "Scoliosis in Gordon's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Scoliosis in Gordon's Syndrome shares the characteristics of an arthrogrypotic neuromuscular curve and demands extensive soft tissue release for optimal correction."
    explanation: Surgical guidance from a case of scoliosis in Gordon syndrome.
  - reference: PMID:33104047
    reference_title: "A review of the orthopedic interventions and functional outcomes among a cohort of 114 children with arthrogryposis multiplex congenita."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "In terms of walking ability, 98% of participants with DA were independent ambulators."
    explanation: >-
      Functional outcome after orthopedic management in a distal arthrogryposis
      cohort. Indirect because the cohort pools distal arthrogryposis types and
      does not report Gordon syndrome separately.
- name: Dental management adapted to limited mouth opening
  description: >-
    Limited mouth opening and impaired manual dexterity make oral hygiene
    difficult; management relies on individualized home care and regular
    dental review, with extractions and restorations possible under local
    anaesthesia.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: dental care
    term:
      id: NCIT:C38052
      label: Dental Procedure
  target_phenotypes:
  - preferred_term: Limited mouth opening
    term:
      id: HP:0000211
      label: Trismus
  evidence:
  - reference: PMID:34038001
    reference_title: "Gordon syndrome: Dental implications and a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Dental management should focus on ensuring that the patient is able to maintain good oral hygiene by customising homecare for the individual and regular dental visits."
    explanation: Dental management recommendations for Gordon syndrome.
animal_models:
- name: Gain-of-function Piezo2 E2799del knock-in mouse
  species: Mouse
  genotype: Piezo2 E2799del (equivalent of human PIEZO2 E2727del), Cre-dependent knock-in, heterozygous
  publication: PMID:36634173
  description: >-
    Mouse carrying the mouse equivalent of the human distal arthrogryposis
    type 5 variant E2727del, expressed constitutively or restricted by Cre
    driver to proprioceptive neurons (Pvalb), all sensory neurons (Advillin,
    inducible) or limb mesenchyme (Prrx1). Constitutive and
    proprioceptor-restricted mice develop hindlimb contractures and shortened tendons;
    mesenchyme-restricted mice do not. Botulinum toxin injected into the
    hindlimb at postnatal days 7 to 10, or a maternal diet enriched in
    eicosapentaenoic acid, which shortens PIEZO2 inactivation, reduced the
    defects.
  modeled_mechanisms:
  - target: Excessive Mechanotransduction in Proprioceptive Sensory Neurons
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Shows that gain-of-function PIEZO2 acting in proprioceptive sensory
      neurons, not in limb mesenchyme, is sufficient for the contractures.
    limitations: >-
      Models a distal arthrogryposis type 5 allele (E2727del), not the
      Gordon syndrome variant p.Arg2686His. The sensitive window was postnatal
      days 7 to 21 in the mouse, whereas human contractures are present at
      birth.
    divergences:
    - divergence_type: POPULATION_MISMATCH
      materiality: QUALIFYING
      description: >-
        The engineered allele is the DA5 variant E2727del. Gordon syndrome
        families mostly carry p.Arg2686His, which has not been modelled, so the
        mechanism is transferred across alleles of the same gene.
    - divergence_type: TEMPORAL_SCOPE
      materiality: QUALIFYING
      description: >-
        The critical window identified is postnatal in mice; whether it maps
        onto fetal development in humans, where contractures are congenital,
        is not tested.
    evidence:
    - reference: PMID:36634173
      reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "These data suggest that overactive PIEZO2 in sensory neurons, but not in mesenchyme, is sufficient to induce DA5-like phenotypes in vivo."
      explanation: Cell-type-restricted expression places the mechanism in sensory neurons.
  - target: Tendon Shortening and Disrupted Musculoskeletal Development
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: Reproduces tendon shortening in the hindlimb.
    limitations: >-
      Mouse hindlimb only; forelimbs were too small to quantify. Tendon length
      has not been measured in people with Gordon syndrome in the cited
      sources.
    readouts:
    - name: Hindlimb tendon length
      target: Tendon Shortening and Disrupted Musculoskeletal Development
      direction: DECREASED
      interpretation: Tendons shorter than in wild-type littermates.
      evidence:
      - reference: PMID:36634173
        reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "we observed that the average length of tendons was significantly reduced in GOFconst. mice compared to wild type"
        explanation: The tendon-length measurement behind this readout.
  - target: Congenital Distal Joint Contractures
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      Reproduces distal hindlimb contractures and reduced limb function, and
      shows that early intervention reduces them.
    limitations: >-
      Contractures arise postnatally in the mouse. Palate, stature and
      ocular features are not among the reported readouts, so the model
      covers the limb component of the disorder only.
    readouts:
    - name: Hindlimb phalange-metacarpal joint angle
      target: Congenital Distal Joint Contractures
      direction: DECREASED
      interpretation: Smaller joint angles indicate contracture.
      evidence:
      - reference: PMID:36634173
        reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "phalange-metacarpal angles in hindlimbs of GOFconst. mice were significantly decreased compared to wild type mice"
        explanation: The joint-angle measurement behind this readout.
    - name: Joint and tendon defects after intramuscular botulinum toxin
      target: Congenital Distal Joint Contractures
      direction: RESTORED
      interpretation: >-
        A single injection at postnatal days 7 to 10 rescued joint and tendon
        defects in the injected limb.
      evidence:
      - reference: PMID:36634173
        reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Meanwhile, it rescued joint and tendon defects in the hindlimb that received the treatment in GOF Piezo2 mice compared to hindlimb injected with vehicle control"
        explanation: Botulinum toxin rescue of the contracture readout.
    - name: Joint malformation after maternal dietary eicosapentaenoic acid
      target: Congenital Distal Joint Contractures
      direction: RESTORED
      interpretation: Partial prevention of joint malformations.
      evidence:
      - reference: PMID:36634173
        reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Finally, we observed that dietary EPA partially prevented joint malformations"
        explanation: Dietary EPA partial rescue of the contracture readout.
discussions:
- discussion_id: gordon_sensory_neuron_mechanism_translation
  prompt: >-
    Does the Gordon syndrome variant p.Arg2686His act through the same
    proprioceptive-neuron efferent mechanism shown for a distal arthrogryposis
    type 5 allele in mice, and is there a corresponding developmental window in
    humans during which reducing PIEZO2 activity would prevent contractures?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Excessive Mechanotransduction in Proprioceptive Sensory Neurons
  - animal_models#Gain-of-function Piezo2 E2799del knock-in mouse
  rationale: >-
    The sensory-neuron mechanism and the botulinum toxin and EPA rescues come
    from a mouse carrying the DA5 allele E2727del, with a postnatal critical
    window. Gordon syndrome is mostly caused by p.Arg2686His, which has not
    been electrophysiologically characterized or modelled in the cited
    sources, and its contractures are present before birth. Whether the
    mechanism and the window transfer decides whether the mouse rescues have
    any bearing on Gordon syndrome.
  evidence:
  - reference: PMID:36634173
    reference_title: "Excessive mechanotransduction in sensory neurons causes joint contractures."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We also present proof-of-concept that Botox injection or dietary treatment can counteract the effect of overactive PIEZO2 function to evade DA-like phenotypes in mice when applied during a developmental critical period."
    explanation: The rescue is shown in mice and only within a developmental window.
notes: >-
  Scope. This entry covers Gordon syndrome (distal arthrogryposis type 3,
  MONDO:0007252, OMIM:114300, ORPHA:376). Distal arthrogryposis type 5
  (MONDO:0007158) and Marden-Walker syndrome (MONDO:0009564) are allelic
  PIEZO2 disorders that McMillin et al. (PMID:24726473) suggest may be one
  condition with variable expressivity. MONDO keeps all three as separate
  concepts; Marden-Walker syndrome has its own entry and DA5 has a separate
  curation stub, so neither is folded in here as a subtype. Both are listed
  as differential diagnoses. The first pathophysiology node uses the same
  name as the Marden-Walker syndrome entry because the molecular lesion is the
  same.

  Name collision. "Gordon syndrome" is also an eponym for pseudohypoaldosteronism
  type 2 (familial hyperkalemic hypertension, MONDO:0019162; WNK1, WNK4,
  KLHL3, CUL3), an unrelated renal tubular disorder. A literature search for
  "Gordon syndrome" returns papers on both, and none of the
  pseudohypoaldosteronism papers are used here. A 2024 osteopathic case report
  (PMID:39559612) describes a patient with distal arthrogryposis features but
  also attributes WNK and WNK4 mutations to her, mixing the two entities, so
  it is not cited.

  Loss of function is a different disorder. Biallelic PIEZO2 loss-of-function
  variants cause a recessive arthrogryposis with muscular atrophy, perinatal
  respiratory distress, scoliosis and impaired proprioception and touch
  (MONDO:0014941, a separate curation stub). The opposite channel effect,
  recessive inheritance and sensory loss distinguish it, so a PIEZO2 variant
  found in a person with contractures needs zygosity and position before it
  can be interpreted.

  Other reports. Two people with Gordon syndrome and congenital myopathy, one
  of whom had malignant hyperthermia, are reported in PMID:24878349; their
  relationship to PIEZO2 is not established and these features are not
  curated as phenotypes. No GeneReviews chapter covers Gordon syndrome.
📚

References & Deep Research

References

3
Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5.
No top-level findings curated for this source.
Excessive mechanotransduction in sensory neurons causes joint contractures.
No top-level findings curated for this source.
Gordon syndrome
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: Gordon_Syndrome · 2026-10-14T21:36:29Z · View source

Created the Gordon syndrome (distal arthrogryposis type 3, MONDO:0007252) entry and deleted its curation stub. Gene: PIEZO2 (hgnc:26270), heterozygous, with the recurrent c.8057G>A (p.Arg2686His) variant and a fetal nonsense variant of uncertain significance recorded under genetic.variants. Pathograph: PIEZO2 gain of function (molecular; node name shared with the Marden-Walker syndrome entry) leads to excess mechanotransduction in proprioceptive sensory neurons (cellular), then tendon shortening and disrupted musculoskeletal development (tissue), then congenital distal joint contractures, which point to the distal arthrogryposis, camptodactyly, clubfoot, large-joint contracture and scoliosis phenotypes. Separate branches from the PIEZO2 node reach an incomplete secondary palate fusion node (cleft palate, bifid uvula), ptosis and Dandy-Walker malformation; these edges rest on genotype-phenotype associations and are marked INDIRECT_UNKNOWN_INTERMEDIATES. The sensory-neuron and tendon nodes are PROVISIONAL because they come from a mouse carrying the DA5 allele E2727del, not the Gordon syndrome variant; that gap is recorded as a HUMAN_MODEL_MISMATCH discussion and as typed divergences on the animal model links. 9 of 18 phenotypes are causally connected; the rest (short stature, high palate, micrognathia, limited mouth opening, pectus excavatum, cryptorchidism, decreased muscle mass, hearing impairment, mild intellectual disability) have no sourced mechanism and are left unconnected. Scope: DA5 (MONDO:0007158, open stub) and Marden-Walker syndrome (existing entry) are kept as separate entries and listed as differential diagnoses, as is the recessive PIEZO2 loss-of-function disorder (MONDO:0014941, open stub). Notes record the eponym collision with pseudohypoaldosteronism type 2. Deep research: one OpenScientist report (research/Gordon_Syndrome-deep-research-openscientist.md). Reference validation 19/19 resolved, 0 off topic; term validation needs_review with 2 mislabelled terms (MONDO:0007252 and GO:0005886, both formatting artifacts). just preflight-dr returned PASS (PIEZO2 mentioned 66 times, OMIM 114300 matches). Errors found in the report on reading: it gives Orphanet as ORPHA:375 (the record is ORPHA:376), says Orphanet classes prevalence as below 1 in 1,000,000 (the Orphanet record says unknown), reports 10/12 GS families where the source says individuals, and offers CL:0000100 for proprioceptive sensory neuron, which is motor neuron in CL (term validation did not flag it because the report gave no label). None of these were carried into the entry; CL:1001451 (sensory neuron of dorsal root ganglion) is used instead. The report's statement that reduced fetal movement causes the contractures is not supported by its cited sources and was not used. Report citations not used: PMID:39147733 and PMID:35586339 (PIEZO2 lipid and cytoskeletal gating, not disease-specific), PMID:36317804 (lethal respiratory DA5, not Gordon syndrome), PMID:41531622 (recessive PIEZO2 duplications), PMID:38349741 (C. elegans DA5 allele; reproductive phenotypes with no Gordon syndrome counterpart). PMID:24878349 (congenital myopathy and malignant hyperthermia in two people with Gordon syndrome) is mentioned in notes only, because the relationship to PIEZO2 is not established. Literature found outside the report: PMID:7258227, 8370149, 458832, 27714920, 37587573, 36588752, 34038001, 11152147, 27607563, 28728825, and the Orphanet record ORPHA:376. PMID:39559612 was read and excluded because it attributes WNK1/WNK4 mutations to a patient with Gordon syndrome, mixing the arthrogryposis with pseudohypoaldosteronism type 2. No GeneReviews chapter exists (just check-genereviews --online: NO_CHAPTER). Validation: just validate passed, 84/84 snippets verified, validate-terms passed, entity refs, causal targets, duplicate keys, enum values, folded hyphens and block-scalar checks clean.

OpenScientist ▸
Gordon Syndrome (Distal Arthrogryposis Type 3): A Comprehensive Disease Characteristics Report
openscientist-autonomous 18 citations 2026-10-14T21:31:44.522948

Gordon Syndrome (Distal Arthrogryposis Type 3): A Comprehensive Disease Characteristics Report

Disease: Gordon Syndrome (Distal Arthrogryposis type 3, DA3) MONDO ID: MONDO:0007252 · OMIM: #114300 · Category: Mendelian (monogenic, autosomal dominant) Causal gene: PIEZO2 (HGNC:26270) · Report date: 2026-10-14 · Evidence base: 32 papers reviewed, 7 confirmed findings.


Summary

Gordon Syndrome (GS), also called distal arthrogryposis type 3 (DA3), is a rare autosomal-dominant congenital contracture disorder. Its defining clinical triad is camptodactyly (permanently flexed fingers), talipes equinovarus (clubfoot), and cleft palate, usually accompanied by short stature and frequently by ptosis and a distinctive facies. GS is distinguished from the broader distal arthrogryposis family chiefly by the presence of cleft palate and short stature. The disease is caused by heterozygous gain-of-function (GoF) missense variants in PIEZO2 (18p11.22), the gene encoding the principal mechanically activated cation channel for proprioception and touch. A single recurrent variant, c.8057G>A / p.Arg2686His, accounts for the majority of molecularly confirmed families and is statistically associated with the cleft-palate phenotype that defines GS.

Mechanistically, GS is a channelopathy of mechanotransduction. The GoF variants, concentrated in the C-terminal pore/inactivation module of PIEZO2, alter channel inactivation kinetics so that the channel carries excess mechanically activated current. In proprioceptive sensory neurons that innervate muscle spindles and tendons, this excessive mechanotransduction during fetal/postnatal development produces neurogenic joint contractures. This causal chain is directly demonstrated in mice: expressing a GoF Piezo2 allele selectively in proprioceptors is sufficient to reproduce distal-arthrogryposis-like contractures, and the deficits are mitigated by botulinum toxin and by a PIEZO2-modulating dietary fatty acid. GS sits at one end of a continuous dominant PIEZO2 clinical spectrum that also includes distal arthrogryposis type 5 (DA5) and Marden-Walker syndrome (MWS); the same variant can produce different points on this spectrum, reflecting marked allelic heterogeneity and variable expressivity.

This report synthesizes evidence from exome-sequencing cohorts, biophysical electrophysiology, mouse and C. elegans models, and clinical case series to populate all 15 requested knowledge-base sections. Information is derived from aggregated disease-level resources (OMIM, Orphanet, published cohorts) rather than EHR-level individual-patient data. Where evidence is absent or not applicable (e.g., infectious agents, somatic variants, cancer survival statistics), this is stated explicitly.


Key Findings

Finding 1 — PIEZO2 is the causal gene; recurrent p.Arg2686His defines Gordon Syndrome

Exome sequencing of five GS-affected families identified PIEZO2 mutations in every family, establishing PIEZO2 as the causal gene for Gordon syndrome (PMID: 24726473). In the pooled DA3/DA5/MWS cohort, PIEZO2 mutations were found in 10/12 (83%) GS families, 24/29 (82%) DA5 families, and 1/2 MWS families. Nine GS families carried the identical c.8057G>A (p.Arg2686His) allele, and the presence of cleft palate — the trait that distinguishes GS from other distal arthrogryposes — was significantly associated with c.8057G>A (Fisher's exact test, adjusted p < 0.0001). The study states: "Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family" and "The presence of cleft palate was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001)." This firmly links a specific recurrent allele to the GS phenotype.

Finding 2 — Disease variants are gain-of-function, acting through altered channel inactivation

Patch-clamp electrophysiology of PIEZO2 disease mutants shows a gain-of-function biophysical signature. Both the E2727del and I802F mutations cause the PIEZO2-dependent mechanically activated currents to recover faster from inactivation, and E2727del additionally slows inactivation — net effect, more channel activity for a given mechanical stimulus (PMID: 23487782): "both E2727del and I802F mutations cause the PIEZO2-dependent, mechanically activated currents to recover faster from inactivation, while E2727del also causes a slowing of inactivation." Critically, "overexpression of mutated PIEZO2 cDNAs does not cause constitutive activity or toxicity to cells, indicating that the observed phenotype is likely due to a mechanotransduction defect." This excludes a toxic/misfolding mechanism and pins the disease on altered mechanotransduction gating rather than cell death. A bioinformatics survey (PMID: 30988732) corroborates that dominant mutations cluster in the C-terminal region and that GoF variants increase PIEZO2 channel activity, while recessive loss-of-function variants cluster N-terminally.

Finding 3 — The contractures are neurogenic: excessive proprioceptor mechanotransduction

The causal link between channel GoF and joint contractures is established in vivo. Expressing a gain-of-function Piezo2 mutation specifically in proprioceptive sensory neurons that innervate muscle spindles and tendons is sufficient to induce DA5-like contractures in mice, via increased peripheral nervous-system activity during postnatal development (PMID: 36634173): "expression of a gain-of-function PIEZO2 mutation in proprioceptive sensory neurons that mainly innervate muscle spindles and tendons is sufficient to induce DA5-like phenotypes in mice." Importantly, the same study shows the phenotype is treatable at the mechanistic level: "botulinum toxin (Botox) and a dietary fatty acid that modulates PIEZO2 activity reduce DA5-like deficits." This identifies the proprioceptive sensory neuron (CL:0000100) as the critical cell type and reframes the contractures as a sensory-neuron-driven (neurogenic), not primarily myopathic or skeletal, process.

Finding 4 — Clinical triad frequencies and reduced, sex-influenced penetrance

Clinical cohort data quantify the core phenotype. Gordon's syndrome presents with short stature, stiff spine, camptodactyly (89%), cleft palate (27%), and club feet (73%) (PMID: 11718203). The original large pedigree established "autosomal dominant inheritance with reduced penetrance and variable expressivity. Penetrance appears to be more reduced in females than in males, and cleft palate is the least frequently manifested trait" (PMID: 458832). These data underpin the frequency annotations and inheritance characteristics below.

Finding 5 — Allelic dichotomy: dominant GoF (C-terminal) vs. recessive LOF (N-terminal/central)

PIEZO2 shows a clean genotype–mechanism dichotomy. Heterozygous gain-of-function missense mutations, mainly at the C terminus, cause dominant DA3 (Gordon)/DA5/MWS: "heterozygous gain-of-function missense mutations, mainly localized at the C terminus, cause dominant distal arthrogryposis 3 (DA3), distal arthrogryposis 5 (DA5), or Marden-Walker syndrome (MWKS)" (PMID: 27843126). In contrast, biallelic loss-of-function (frameshift/deletion) variants in the N-terminal/central regions cause a distinct recessive syndrome — "leading to nonsense-mediated transcript decay and consequently to lack of PIEZO2 protein" — characterized by muscular atrophy, perinatal respiratory distress (spontaneously resolving), arthrogryposis, scoliosis, and mild distal sensory loss. This dichotomy is essential for variant interpretation: the mechanism (and thus inheritance and recurrence risk) depends on variant type and location.

Finding 6 — Model organisms recapitulate the mechanism

Animal models validate both the normal function and the disease mechanism. Conditional deletion of Piezo2 in mouse proprioceptors abolishes rapidly adapting mechanically activated currents and produces balance/coordination deficits — "Piezo2 fulfills a critical role in a defined homogeneous population of proprioceptor neurons... demonstrating that this ion channel is essential for mammalian proprioceptive mechanotransduction" (PMID: 27184818). A GoF knock-in mouse reproduces contractures (PMID: 36634173). In C. elegans, CRISPR knock-in of the conserved GoF variant pezo-1[R2405P] (equivalent to human PIEZO2 R2718P, which causes DA5) is electrophysiologically gain-of-function and causes reproductive and actin-organization defects — "a conserved gain-of-function variant pezo-1[R2405P] that in human PIEZO2 causes distal arthrogryposis type 5 (DA5; p. R2718P)" (PMID: 38349741); the phenotype is suppressible by the F-actin regulator gex-3/NCKAP1, implicating the cytoskeleton in PIEZO2 gating.

Finding 7 — Gordon Syndrome lies on a continuous PIEZO2 spectrum

GS is not a discrete entity but one pole of a continuum. A review of individuals sharing the recurrent p.Arg2686His variant and other alleles demonstrates "marked phenotypic variability-from Gordon syndrome to distal arthrogryposis type 5-underscoring allelic heterogeneity and variable expressivity" (PMID: 41572728). An independent cohort describing a classic MWS patient with a C-terminal truncating variant (c.8237G>A/p.W2746*) alongside a GS girl with the prevalent c.8057G>A/p.R2686H further corroborates a dominant PIEZO2 continuum (PMID: 36588752).


Mechanistic Model / Causal Chain

Ordered mechanistic sequence (initiating lesion → clinical manifestation)

  1. A heterozygous gain-of-function missense variant in PIEZO2 (most often c.8057G>A / p.Arg2686His), located in the C-terminal pore/inactivation module, arises de novo or is inherited (autosomal dominant). [demonstrated — PMID 24726473]
  2. The variant alters channel inactivation kinetics — slowing inactivation and/or speeding recovery from inactivation — which leads to increased mechanically activated cation (Na⁺/Ca²⁺) current for a given mechanical stimulus (GoF). [demonstrated in vitro — PMID 23487782]
  3. Excess PIEZO2 current results in heightened mechanotransduction specifically in proprioceptive sensory neurons innervating muscle spindles and tendons. [demonstrated — PMID 36634173]
  4. Heightened proprioceptor activity during fetal and postnatal development leads to increased peripheral nervous-system drive to developing muscle/joint units. [demonstrated in mouse — PMID 36634173]
  5. Abnormal sensory-motor drive and reduced fetal movement result in neurogenic joint contractures (camptodactyly, clubfoot) and short stature. [inferred for human; demonstrated phenotype in mouse model]

Branch A (GS-defining): The p.Arg2686His allele is statistically associated with cleft palate (adjusted p < 0.0001), the trait distinguishing GS/DA3 from DA5 — the mechanism of the palatal branch (likely diminished fetal orofacial movement/mechanical patterning) is inferred. [association demonstrated — PMID 24726473; mechanism inferred]

Branch B: Other C-terminal alleles shift the phenotype toward DA5 (ptosis, ophthalmoplegia, no cleft palate) or Marden-Walker syndrome (CNS involvement), producing the continuous spectrum. [demonstrated — PMID 27843126, 41572728]

  1. Contractures and craniofacial/skeletal anomalies manifest at birth as the congenital, non-progressive GS phenotype; variable expressivity and reduced (female-biased) penetrance modulate which features appear. [demonstrated — PMID 458832]

Contrast with the recessive branch

PIEZO2 variant
│
├── C-terminal MISSENSE, heterozygous ─── GAIN of function ─── ↑ mechanotransduction
│     └── DOMINANT: DA3 (Gordon) / DA5 / Marden-Walker  (a continuous spectrum)
│
└── N-terminal/central FRAMESHIFT/DELETION, biallelic ─── NMD → NO protein ─── LOSS of function
      └── RECESSIVE: muscular atrophy, perinatal respiratory distress,
          arthrogryposis, scoliosis, distal sensory loss

Pathways, processes, and ontology anchors

  • Molecular pathway: Mechanically activated cation channel signaling / mechanotransduction (not a classic Wnt/MAPK/mTOR pathway). Gating is lipid-modulated — phosphatidic acid and LPA are endogenous negative regulators of PIEZO2 (PMID: 39147733) — and cytoskeleton/ECM-coupled (PMID: 35586339).
  • GO biological process: detection of mechanical stimulus (GO:0050982), proprioception, ion transmembrane transport (GO:0034220), sensory perception of touch (GO:0050975).
  • GO molecular function: mechanosensitive monoatomic cation channel activity (GO:0140135).
  • GO cellular component: plasma membrane (GO:0005886); PIEZO2 is a trimeric propeller-shaped plasma-membrane channel.
  • Cell type (CL): proprioceptive/sensory neuron (CL:0000100), muscle-spindle–associated sensory neuron.
  • Upstream vs downstream: Upstream = PIEZO2 GoF variant → altered gating; midstream = excess proprioceptor mechanotransduction; downstream = neurogenic contractures and secondary skeletal/craniofacial manifestations.

Section-by-Section Report

1. Disease Information

Gordon Syndrome is a rare autosomal-dominant distal arthrogryposis characterized by the triad of camptodactyly, clubfoot, and cleft palate, usually with short stature. It is distinguishable from other distal arthrogryposes primarily by cleft palate and short stature.

Resource Identifier
MONDO MONDO:0007252
OMIM #114300
Orphanet ORPHA:375 (Gordon syndrome / distal arthrogryposis type 3)
MeSH Arthrogryposis (indexed via Distal Arthrogryposis / PIEZO2)
ICD-10 Q74.3 (Arthrogryposis multiplex congenita) — no GS-specific code
ICD-11 LD28.1 / arthrogryposis grouping (no GS-specific code)
Gene PIEZO2 (HGNC:26270), 18p11.22

Synonyms / alternative names: Distal arthrogryposis type 3 (DA3); Camptodactyly–cleft palate–clubfoot; Gordon's syndrome. Data source type: Aggregated disease-level resources and published case series/cohorts (OMIM, Orphanet, PubMed) — not individual EHR data.

2. Etiology

  • Primary cause — genetic: Heterozygous gain-of-function missense variants in PIEZO2 (PMID: 24726473). No environmental, infectious, or toxic cause is implicated.
  • Genetic risk factors: The causal variant itself is the risk factor; recurrent p.Arg2686His is by far the most common. No separate susceptibility loci or validated human modifier genes are known (the C. elegans suppressor gex-3/NCKAP1 is an experimental modifier of a PIEZO2 GoF phenotype — PMID: 38349741).
  • Environmental risk factors: None established. As a monogenic congenital disorder, environmental exposures are not causal. Advanced paternal age is a general (not GS-specific) consideration for de novo variants.
  • Protective factors: None genetic known. Experimentally, phosphatidic acid/LPA negatively regulate PIEZO2 (PMID: 39147733) and a dietary fatty acid reduces the contracture phenotype in mice (PMID: 36634173) — candidate protective/therapeutic modulators, not established human protective factors.
  • Gene–environment interactions: Not applicable / none established for this monogenic disorder.

3. Phenotypes

Phenotype HPO term (suggested) Type Frequency Onset / course
Camptodactyly HP:0012385 Clinical sign / physical ~89% Congenital, non-progressive
Talipes equinovarus (clubfoot) HP:0001762 Physical malformation ~73% Congenital, non-progressive
Cleft palate HP:0000175 Physical malformation ~27% (GS-defining; assoc. R2686H) Congenital
Short stature HP:0004322 Physical Common Congenital/childhood
Ptosis HP:0000508 Clinical sign Frequent (esp. DA5 end) Congenital
Scoliosis / stiff spine HP:0002650 Physical Reported Childhood, may progress
Distinctive facies HP:0001999 Physical Variable Congenital
Bifid uvula HP:0000193 Physical Reported (mild palatal end) Congenital
Mild intellectual disability / psychomotor delay HP:0001256 / HP:0001263 Behavioral/cognitive Occasional (spectrum) Childhood

Frequencies from PMID: 11718203; psychomotor delay/ID occasionally reported (PMID: 27714920). Severity: mild to moderate, variable. Progression: congenital and essentially non-progressive (contractures static, though scoliosis can progress). Quality-of-life impact: contractures affect fine motor function and ambulation; cleft palate affects feeding/speech; most distal-arthrogryposis patients achieve independent ambulation and self-care (PMID: 33104047). No GS-specific EQ-5D/SF-36 data available.

4. Genetic / Molecular Information

  • Causal gene: PIEZO2 (HGNC:26270; NCBI Gene 63895; UniProt Q9H5I5), chromosome 18p11.22; phenotype OMIM #114300.
  • Pathogenic variants: Predominantly missense, concentrated in the C-terminal pore/inactivation module. Recurrent GS allele: c.8057G>A, p.Arg2686His. Other spectrum alleles include p.Arg2718Leu/Pro, p.Glu2727del, p.Thr2221Ile, p.Ser2690Arg, p.Met998Ile, and truncating C-terminal p.W2746. Novel GS alleles continue to be reported (e.g., c.8576G>A/p.Trp2859 in a fetus — PMID: 37587573).
  • Variant classification (ACMG/AMP): Recurrent C-terminal missense variants are classified pathogenic/likely pathogenic; several newly described alleles are initially VUS pending segregation/functional data.
  • Allele frequency: Pathogenic GS alleles are absent or ultra-rare in gnomAD (consistent with a severe dominant developmental disorder).
  • Somatic vs germline: Germline (constitutional). De novo occurrence is common; germline mosaicism is possible but rarely documented (PMID: 37587573).
  • Functional consequence: Gain of function — altered inactivation increasing mechanically activated current (PMID: 23487782). Contrast: biallelic N-terminal LOF → recessive disease (PMID: 27843126).
  • Modifier genes: None validated in humans; gex-3/NCKAP1 modifies PIEZO2 GoF in C. elegans (PMID: 38349741).
  • Epigenetic information: No disease-specific DNA-methylation/histone data available.
  • Chromosomal abnormalities: Not a feature of classic GS; rare intragenic PIEZO2 duplications cause a distinct recessive phenotype (PMID: 41531622).

5. Environmental Information

Not applicable. GS is a monogenic germline disorder. No environmental factors, lifestyle factors, or infectious agents are implicated in causation or triggering. (Note: congenital myopathy co-occurrence and malignant hyperthermia susceptibility have been reported in isolated GS cases, relevant to anesthetic exposure — PMID: 24878349.)

6. Mechanism / Pathophysiology

See the Mechanistic Model / Causal Chain section above for the ordered sequence. In brief: C-terminal PIEZO2 GoF variant → altered channel inactivation → excess mechanically activated current → hyperactive proprioceptive sensory-neuron mechanotransduction during development → reduced fetal movement and neurogenic joint contractures → congenital GS phenotype, with the R2686H allele branching toward cleft palate and other alleles branching toward DA5/MWS. Key molecular detail: PIEZO2 gating is lipid-modulated (phosphatidic acid/LPA are negative regulators; PMID: 39147733) and cytoskeleton/ECM-coupled (PMID: 35586339). No primary metabolic, immune, oxidative-stress, or fibrotic mechanisms are involved; the disorder is a developmental channelopathy. GO/CL anchors as listed above.

7. Anatomical Structures Affected

  • Organ/system — primary: Musculoskeletal system (hands/fingers, feet/ankles, spine), craniofacial structures (palate), peripheral nervous system (proprioceptive afferents — the mechanistic primary site). UBERON: skeletal joint (UBERON:0000982), manual digit (UBERON:0002389), foot (UBERON:0002387), secondary palate (UBERON:0001716), peripheral nerve.
  • Secondary involvement: Extraocular muscles (ptosis/ophthalmoplegia at DA5 end), respiratory system (restrictive pulmonary function at the severe end, PMID: 36317804), vertebral column (scoliosis).
  • Tissue/cell level: Peripheral sensory neurons (proprioceptors innervating muscle spindles/tendons) are the critical cell population — CL:0000100; secondarily skeletal muscle and periarticular connective tissue.
  • Subcellular level: Plasma membrane mechanosensitive channel (GO:0005886); gating coupled to cortical actin cytoskeleton.
  • Localization / lateralization: Contractures are typically bilateral and symmetric (hands and feet).

8. Temporal Development

  • Onset: Congenital — contractures detectable prenatally by ultrasound (as early as ~13 weeks gestation; PMID: 27714920) and present at birth.
  • Onset pattern: Developmental/congenital (not acute).
  • Progression: Contractures are non-progressive/static; scoliosis may progress through growth and requires monitoring. No oncologic-style "stages."
  • Disease course: Chronic/lifelong structural phenotype; the underlying channel defect is constitutive.
  • Remission: No spontaneous remission; orthopedic interventions improve function.
  • Critical period: Fetal/early-postnatal development is the window during which excess mechanotransduction produces contractures — identifying a potential window for intervention (cf. Botox/fatty-acid rescue in neonatal mice, PMID: 36634173).

9. Inheritance and Population

  • Epidemiology: Very rare; precise prevalence/incidence not established. Orphanet classes GS/DA3 as <1/1,000,000. No reliable incidence figures.
  • Inheritance: Autosomal dominant (PMID: 458832); frequent de novo occurrence.
  • Penetrance: Reduced/incomplete, and more reduced in females than males (PMID: 458832).
  • Expressivity: Variable, including intrafamilial variability and overlap across GS/DA5/MWS with identical alleles (PMID: 41572728).
  • Genetic anticipation: Not a feature (not a repeat-expansion disorder).
  • Germline mosaicism: Rarely documented but possible (PMID: 37587573).
  • Founder effects / consanguinity: Not applicable to the dominant form (consanguinity is relevant to the recessive biallelic-LOF PIEZO2 disorder, PMID: 27843126).
  • Carrier frequency: Not applicable (dominant).
  • Population demographics: No ethnic predilection reported; cases described worldwide (Europe, China, Brazil, Saudi Arabia, Canada). Sex ratio: females may be under-ascertained owing to reduced female penetrance. Age distribution: diagnosed prenatally/at birth/in childhood.

10. Diagnostics

  • Clinical diagnosis: Based on the triad (camptodactyly + clubfoot + cleft palate) plus short stature; physical exam and dysmorphology.
  • Imaging: Prenatal fetal ultrasound detects contractures/clubfoot/micrognathia and can establish a prenatal diagnosis when combined with genetic testing (PMID: 37587573); skeletal radiographs for contractures/scoliosis.
  • Genetic testing (confirmatory, recommended):
  • Single-gene PIEZO2 sequencing or distal arthrogryposis / arthrogryposis gene panels (Sanger confirmation of recurrent c.8057G>A is efficient when the phenotype is classic).
  • Whole-exome sequencing (WES) — the discovery and workhorse modality (PMID: 24726473, PMID: 37587573).
  • Whole-genome sequencing (WGS) — useful when panels/WES negative.
  • Chromosomal microarray — not diagnostic for point-variant GS, but detects the rare duplication/CNV forms (PMID: 41531622).
  • Karyotype/FISH/mtDNA/repeat-expansion testing: not applicable.
  • Laboratory tests / biomarkers: No specific biochemical biomarker; diagnosis is clinical + molecular. (Creatine kinase and muscle biopsy occasionally relevant when congenital myopathy co-occurs — PMID: 24878349.)
  • Omics-based diagnostics: Not routinely used.
  • Differential diagnosis: Other distal arthrogryposes (DA1, DA2A/Freeman-Sheldon, DA2B/Sheldon-Hall — TNNI2/TNNT3/TPM2/MYH3), DA5 and Marden-Walker (allelic PIEZO2), multiple pterygium syndrome, amyoplasia, and syndromic cleft palate. Distinguishing features: cleft palate + short stature favor GS/DA3; ptosis/ophthalmoplegia favor DA5; CNS involvement/psychomotor delay favor MWS.
  • Screening: No population newborn screen. Cascade testing of at-risk relatives and prenatal/preimplantation genetic testing available once the familial variant is known.

11. Outcome / Prognosis

  • Survival / life expectancy: Generally normal for classic GS. Exception: the severe respiratory end of the PIEZO2 spectrum can cause lethal neonatal respiratory insufficiency (PMID: 36317804).
  • Mortality: No disease-specific mortality statistics for classic GS; mortality is concentrated in severe/respiratory cases.
  • Morbidity / disability: Chiefly from contractures (hand function, ambulation), scoliosis, and cleft palate (feeding/speech). Most individuals with distal arthrogryposis achieve independent ambulation and self-care with orthopedic management (PMID: 33104047).
  • Quality of life: No GS-specific validated QoL instrument data.
  • Complications: Progressive scoliosis; feeding/speech difficulty from cleft palate; anesthetic risk including reported malignant hyperthermia in a GS case with congenital myopathy (PMID: 24878349).
  • Prognostic factors: Specific PIEZO2 allele and position on the spectrum (respiratory involvement worsens prognosis); severity of scoliosis and contractures.

12. Treatment

There is no disease-modifying/curative therapy; management is supportive, orthopedic, and multidisciplinary.

  • Orthopedic / surgical (NCIT: Orthopedic Procedure): Serial casting and bracing for clubfoot (Ponseti-type), tendon-release/soft-tissue surgery for contractures, scoliosis management (bracing/spinal surgery). Distal-arthrogryposis orthopedic cohorts show good functional outcomes (PMID: 33104047).
  • Craniofacial surgery (NCIT: Palatoplasty): Cleft palate repair with speech therapy follow-up.
  • Rehabilitation (NCIT: Physical Therapy / Occupational Therapy): Physiotherapy, occupational therapy, and speech therapy for contractures, mobility, fine motor skills, and feeding/speech.
  • Pharmacotherapy: No approved drug. Mechanism-targeted candidates (experimental, preclinical): botulinum toxin (NCIT: Botulinum Toxin) and a PIEZO2-modulating dietary fatty acid reduced DA-like deficits in mice (PMID: 36634173); phosphatidic acid/LPA-based PIEZO2 inhibition is a plausible future strategy (PMID: 39147733). These are not established human treatments.
  • Advanced therapeutics (gene/cell/RNA therapy): None available; a GoF mechanism is in principle amenable to allele-selective silencing (ASO/siRNA) — conceptual only.
  • Anesthetic caution: Given reported malignant hyperthermia/congenital myopathy associations, anesthetic planning should consider MH precautions (PMID: 24878349).
  • Personalized medicine: Genotype confirms diagnosis and informs recurrence risk/prenatal options; no genotype-guided pharmacotherapy yet.

13. Prevention

  • Primary prevention: Not possible (congenital genetic disorder). Genetic counseling is central: autosomal-dominant 50% transmission risk from an affected parent, with reduced (female-biased) penetrance and variable expressivity complicating counseling (PMID: 458832).
  • Secondary/tertiary prevention: Early orthopedic intervention and scoliosis surveillance to prevent functional decline; palatoplasty and feeding/speech support.
  • Reproductive options: Once the familial PIEZO2 variant is identified — prenatal diagnosis (CVS/amniocentesis), preimplantation genetic testing (PGT), and cascade testing of relatives.
  • Immunization / public-health / environmental interventions: Not applicable.

14. Other Species / Natural Disease

  • Taxonomy / orthologs: PIEZO2 is evolutionarily conserved. Mouse ortholog Piezo2 (Mus musculus, NCBI:txid10090); C. elegans ortholog pezo-1 (Caenorhabditis elegans, NCBI:txid6239). Human variant positions map to conserved residues (e.g., human R2718P ≈ worm R2405P).
  • Natural disease in other species: No well-documented naturally occurring Gordon-syndrome-equivalent in companion animals/wildlife (OMIA) identified in this review. Veterinary relevance: none established.
  • Comparative biology: Disease mechanisms are evolutionarily conserved at the channel level — the worm GoF knock-in reproduces electrophysiological gain-of-function and physiological defects (PMID: 38349741); mouse Piezo2 is essential for proprioception (PMID: 27184818).
  • Transmission / zoonosis: Not applicable (non-infectious).

15. Model Organisms

Model Type Construct Phenotype recapitulation Reference
Mouse (Mus musculus) Mammalian, in vivo Proprioceptor-specific Piezo2 GoF knock-in High — sufficient to induce DA5-like contractures; Botox + dietary fatty acid rescue PMID: 36634173
Mouse Mammalian, in vivo Conditional Piezo2 knockout in proprioceptors Validates normal function — loss abolishes RA mechanically activated currents, balance/coordination deficits PMID: 27184818
C. elegans Invertebrate pezo-1[R2405P] CRISPR knock-in (≈ human R2718P/DA5) Moderate — GoF electrophysiology + reproductive/actin defects; suppressed by gex-3/NCKAP1 PMID: 38349741
HEK/heterologous cells In vitro PIEZO2 mutant cDNA (E2727del, I802F) Biophysical GoF (altered inactivation); no toxicity PMID: 23487782
  • Applications: Dissecting channel gating, the neurogenic origin of contractures, the developmental critical period, and therapeutic screening (Botox, lipids, dietary fatty acids).
  • Limitations: Mouse GoF studies modeled the DA5 allele/phenotype rather than the GS-specific cleft-palate branch; the orofacial/palatal mechanism remains uncharacterized in models. Invertebrate models cannot capture craniofacial/skeletal features.
  • Resources: MGI (mouse), WormBase (C. elegans), Cellosaurus/ATCC (cell lines).

Evidence Base

PMID Title (abbrev.) Evidence type Supports
24726473 Mutations in PIEZO2 cause GS, MWS, and DA5 Human exome cohort F1 — causal gene, recurrent R2686H, cleft-palate association
23487782 Gain-of-function PIEZO2 mutations cause a DA subtype In vitro electrophysiology F2 — GoF via altered inactivation; no toxicity
36634173 Excessive mechanotransduction in sensory neurons causes joint contractures Mouse in vivo F3 — neurogenic mechanism; Botox/fatty-acid rescue
11718203 Scoliosis in Gordon's syndrome Human clinical F4 — triad frequencies
458832 Gordon syndrome large pedigree Human pedigree F4 — AD inheritance, reduced female penetrance, variable expressivity
27843126 Biallelic loss of PIEZO2... Human + mechanism F5 — dominant GoF vs recessive LOF dichotomy
27184818 Critical role for Piezo2 in proprioceptive mechanotransduction Mouse in vivo F6 — Piezo2 essential for proprioception
38349741 F-actin factor suppresses DA5 PIEZO2 variant in C. elegans Invertebrate model F6 — conserved GoF model; cytoskeletal modifier
41572728 Expanding genotype-phenotype of MWS due to PIEZO2 Human review F7 — same variant → GS↔DA5 continuum
36588752 Continuum in dominant PIEZO2 spectrum Human cohort F7 — dominant PIEZO2 continuum
30988732 Bioinformatics of PIEZO2 mutations Computational F2/F5 — C-terminal dominant GoF vs N-terminal recessive LOF
39147733 Phosphatidic acid negatively regulates PIEZO2 In vitro/mouse Mechanism/therapeutics — lipid modulation
37587573 Novel PIEZO2 variant in a fetus (GS) Human case Prenatal diagnosis; de novo/mosaicism
36317804 Lethal respiratory course in PIEZO2 DA5 Human case Severe end of spectrum / prognosis
24878349 GS with congenital myopathy / malignant hyperthermia Human cases Anesthetic risk; comorbidity
27714920 Familial GS with PIEZO2 mutation Human family Prenatal detection; psychomotor-delay spectrum

Consistency of the evidence: The causal gene and GoF mechanism are supported convergently by human genetics (exome cohorts), in vitro electrophysiology, and two independent animal models — an unusually complete chain for a rare disorder. No study in this corpus contradicts the PIEZO2 GoF model for the dominant spectrum.


Limitations and Knowledge Gaps

  1. The cleft-palate branch is unexplained mechanistically. p.Arg2686His is statistically linked to cleft palate, but no model explains how proprioceptor-channel GoF causes a palatal defect; this step is inferred, not demonstrated.
  2. Models target DA5, not GS specifically. The pivotal mouse GoF study reproduced DA5-like contractures; no model reproduces the GS-defining cleft palate + short stature, so therapeutic rescue data may not transfer directly to GS.
  3. No epidemiology. Prevalence, incidence, sex ratio, and natural-history/QoL data are not quantified for GS specifically.
  4. Therapeutics are preclinical. Botox and fatty-acid/lipid modulation are promising but unproven in humans; no GS clinical trials (NCT identifiers) were identified.
  5. Variant interpretation of novel alleles. Several reported variants remain VUS; functional assays are not routinely performed clinically.
  6. No human omics data (transcriptomics/proteomics/metabolomics) for GS tissue.
  7. Penetrance/expressivity modifiers in humans are uncharacterized (only a worm suppressor is known).

Proposed Follow-up Experiments / Actions

  1. Generate a GS-specific (R2686H) mouse knock-in and assess craniofacial/palatal development to test whether proprioceptor GoF alone, or broader PIEZO2 expression (e.g., in cranial neural crest/orofacial tissues), produces cleft palate — resolving the unexplained branch.
  2. Test lipid/fatty-acid and Botox interventions during the fetal critical window in GS-relevant models, defining dose, timing, and whether palatal and skeletal phenotypes (not just contractures) are modifiable.
  3. Develop allele-selective knockdown (ASO/siRNA) against the recurrent R2686H allele as a mechanism-rational disease-modifying candidate.
  4. Assemble an international GS/PIEZO2 registry to quantify prevalence, penetrance by sex, genotype–phenotype correlations across the GS–DA5–MWS continuum, natural history, and validated QoL outcomes.
  5. Systematic functional classification of VUS (standardized patch-clamp inactivation assays) to accelerate ACMG reclassification and prenatal counseling.
  6. Clinical anesthesia study of malignant-hyperthermia/myopathy risk in PIEZO2 patients to issue evidence-based peri-operative guidance.

Report compiled from 5 autonomous investigation iterations; 7 confirmed findings; 32 papers reviewed. Evidence types span human clinical/genetic cohorts, in vitro electrophysiology, computational analysis, and mouse/C. elegans models. Information derived from aggregated disease-level resources and primary literature, not individual EHR data.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.3.0.

Outcome Count
References checked 19
Resolved 19
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 19
On topic 12
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 23
Resolved 21
Unresolved (possible confabulation) 0
Obsolete 0
Unverifiable 2
Terms whose name was checked 12
Terms named correctly 5
Terms named as a different term 2
Terms whose name is worth a second look 5

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • MONDO:0007252 (2 mentions) - the report calls it "MONDO"; MONDO calls it Gordon syndrome
  • GO:0005886 (2 mentions) - the report calls it "GO cellular component: plasma membrane", "Subcellular level: Plasma membrane mechanosensitive channel"; GO calls it plasma membrane

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • GO:0050982 (1 mention) - the report calls it "GO biological process: detection of mechanical stimulus"; GO calls it detection of mechanical stimulus**
  • GO:0140135 (1 mention) - the report calls it "GO molecular function: mechanosensitive monoatomic cation channel activity"; GO calls it mechanosensitive monoatomic cation channel activity**
  • HP:0001762 (1 mention) - the report calls it "Talipes equinovarus (clubfoot)"; HP calls it Talipes equinovarus
  • HP:0002650 (1 mention) - the report calls it "Scoliosis / stiff spine"; HP calls it Scoliosis
  • HP:0001999 (1 mention) - the report calls it "Distinctive facies"; HP calls it Abnormal facial shape, and lists "Distinctive facies" among its other names

Terms named inconsistently

The report gives these identifiers more than one name of its own:

  • GO:0005886 - called "GO cellular component: plasma membrane", "Subcellular level: Plasma membrane mechanosensitive channel"

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA.